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SUMMARY 
 
DNA replication and DNA repair are two tightly linked processes since, 
on the one hand, errors occurring during replication in germline cells might 
introduce mutations that are handed on to the next generation and, on the other 
hand, unrepaired DNA structures might cause replication blocks that threaten 
genome integrity. DNA and replication fork integrity are monitored by 
checkpoint-mediated phosphorylation events that trigger repair pathways. 
Exonuclease 1 (Exo1) processes stalled replication forks in checkpoint-
defective yeast cells. While studying Exo1 and its regulation by 
phosphorylation and other post-translational modifications, we isolated an 
interesting group of novel in vivo interaction partners in yeast and mammalian 
cells, namely the 14-3-3 proteins. 14-3-3’s are able to bind phosphorylated 
proteins and, in addition to their well-known ability to act as adaptors that 
integrate signals from different pathways, they were shown to play an undefined 
role under DNA replication stress. The finding that they interact with Exo1 led 
us to formulate the hypothesis that the 14-3-3/Exo1 complex might have a 
functional role at replication forks and encouraged us to investigate this 
possibility. 
Using DNA bi-dimensional electrophoresis, we could show that yeast 
14-3-3’s promote fork progression under limiting nucleotide concentrations. 14-
3-3-deficient cells fail to induce Mec1-dependent Exo1 hyper-phosphorylation 
and accumulate Exo1-dependent ssDNA gaps at stalled forks, as revealed by 
electron microscopy. This leads to persistent checkpoint activation and 
exacerbated recovery defects. Interestingly the fork progression defect in 14-3-3 
cells cannot be rescued by Exo1 deletion and the recovery defect is only 
partially rescued by Exo1 deletion, suggesting that additionally to Exo1, 14-3-3 
proteins might regulate the phosphorylation of other yet unknown targets in 
response to replication fork stalling. 
Based on this evidence, we propose that 14-3-3 proteins assist 
checkpoint-mediated phosphorylation of Exo1 and additional unknown targets, 
promoting fork progression, stability and restart in response to DNA replication 
stress. 
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ZUSAMMENFASSUNG 
 
Die Replikation und die Reparatur der DNS sind zwei eng verknüpfte 
Prozesse. Auf der einen Seite können Fehler während der Replikation von 
Keimbahnzellen Mutationen hervorrufen welche an die nächste Generation 
weitervererbt werden. Andererseits können abnormale DNS Strukturen die 
Replikationsgabeln blockieren, was die Integrität des Genoms gefährden kann.  
Die Integrität der DNS und der Replikationsgabeln wird von Checkpoint-
Kinasen überwacht, welche Reparatur Signalkaskaden auslösen können. 
In Hefezellen, welche einen Checkpoint Defekt haben, prozessiert Exo1 
arretierte Replikationsgabeln. Während unserer Studie im Zusammenhang mit 
der Regulierung von Exo1 durch Phosphorylierung und andere post-
translationalen Modifikationen, haben wir eine interessante Gruppe von bisher 
unbekannten in vivo Interaktionspartnern gefunden, die 14-3-3 Proteine. Diese 
sind in der Lage phosphorylierte Proteine zu binden und, zusätzlich zu ihren 
hinreichend bekannten Fähigkeiten als Adaptoren, welche Signale von 
verschiedenen Signalkaskaden integrieren, konnte gezeigt werden, daß sie eine 
bisher nicht genauer definierte Rolle während des DNS Replikationsstresses 
spielen. Die Isolation von 14-3-3 als Interaktionspartner von Exo1, hat uns 
ermuntert die von uns postulierte Hypothese zu untersuchen, welche besagt, daß 
der 14-3-3/Exo1 Komplex eine funktionelle Rolle an Replikationsgabeln spielt. 
Wir konnten anschließend dank der bi-dimensionalen Elektrophorese 
zeigen, daß, wenn die Nukleotidkonzentrationen limitierend sind, 14-3-3 
Proteine die Progression der Replikationsgabeln fördern. In 14-3-3 defizienten 
Zellen wird die Mec1 abhängige Exo1 Hyperphosphorylierung nur mangelhaft 
induziert. Wie wir anhand der applizierten Elektronenmikroskopie zeigen 
konnten, akkumulieren die 14-3-3 defizienten Zellen Exo1 abhängige ssDNS 
Lücken an den arretierten Replikationsgabeln. Diese Lücken führen zu einer 
persistenten Checkpoint Aktivierung und Defekten bei der Erholung vom 
Replikationsblock. Interessanterweise kann der progressions-Defekt der 
Replikationsgabeln nicht durch die Deletion von EXO1 verhindert werden. 
Zusätzlich wird der Defekt während der Erholung vom Replikationsblock nur 
partiell durch die Deletion von EXO1 verhindert. Dies suggeriert, daß zusätzlich 
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zu Exo1, 14-3-3 noch weitere bisher unbekannte Zielproteine über deren 
Phophorylierungs-Status  reguliert, wenn es zu einer Blockierung der 
Replikationsgabeln kommt. 
Gestützt auf diese Resultate postulieren wir, daß 14-3-3 Proteine 
Checkpoint vermittelte Phosphorylierungen auf Exo1 und auf zusätzliche, 
bisher unbekannte Ziele, regulieren, wodurch sie die Progression, die Stabilität 
und den Neustart der Replikationsgabeln fördern. 
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1. INTRODUCTION 
 
1.1. DNA replication and repair 
1.1.1. General features of chromosome replication 
 
The groundwork for understanding of chromosomal replication was laid 
by Crick and Watson and their famous DNA duplex structure model, which 
suggested that the two new DNA strands are copied from the old strand thus 
allowing exact copying of genetic information. The two old strands reassemble 
with two newly synthesized daughter strands in a semiconservative manner. 
Most eukaryotes and prokaryotes carry out DNA replication bidirectionally 
from a given start point, often referred to as origin of replication. Most circular 
DNA molecules present in bacteria and viruses have only one origin of 
replication and the two growing forks merge on the opposite side of the circle to 
complete replication. Multiple origins are present in the long linear 
chromosomal DNA of eukaryotes. Growing forks from neighboring origins 
advance until they meet and likewise complete the replication of one so-called 
replicon. For example the human genome contains about 3*109 base pairs and it 
takes roughly 8 hours to complete DNA replication of the approximately 10.000 
to 100.000 replicons. DNA replication is tightly monitored to ensure accurate 
replication of the chromosomes just once per cell cycle and completion of the 
replication before the onset of mitosis. The sequence of events and the 
components of the DNA replication machinery are highly conserved throughout 
the entire eukaryotic world (Brush and Kelly, 1995). 
 
1.1.2. Initiation of chromosome replication 
 
Whether, when and where DNA replication begins is tightly controlled 
during the initiation step of replication, the origin firing. Replication origins of 
all species share the following properties: Their DNA segments contain multiple 
short repeated sequences. These sequences are recognized by multimer origin 
binding proteins that play a key role in assembling the replisome. Origins of 
replication contain AT rich sequences that facilitate unwinding of duplex DNA. 
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Some organisms, like the budding yeast Saccharomyces cerevisiae, have clear 
replicator sequences called autonomously replicating sequence (ARS), whereas 
many other organisms have less strict DNA sequence requirements for the 
initiation events. The yeast S. cerevisiae is especially useful when it comes to 
studying origins of replication and DNA replication itself. In this model 
organism 400 origins of replication exist on the 17 Chromosomes and a dozen 
of these have been characterized in detail. The yeast origin sequences (ARS), 
when introduced into a plasmid, confer the ability to replicate in yeast. 
Binding of the origin recognition complex (ORC) to the origins allows 
the pre-replicative complex (preRC) to associate on the origins in G1, and the 
recruitment of additional replication factors like cell division control protein 6 
(Cdc6), the chromatin licensing and DNA replication factor 1 (Cdt1) and the 
minichromosome maintenance (MCM) helicase complex to these sites before 
the onset of DNA replication. Chromatin structures are important factors not 
only for transcription but also for origin selection and they seem to affect the 
efficiency of preRC assembly, which may indirectly alter the initiation 
frequency at particular loci, but they are probably not essential for origin firing. 
At each fired origin, two sister replication forks emerge and move away from 
each other and this causes an inhibition of the preRC in order to prevent re-
replication (Masai et al. 2010). 
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Fig.1 Model of a stalled versus unperturbed replication fork 
Modified after: 
Masai H. et al. 
 
1.1.3. The DNA replication machinery 
 
DNA replication is tightly monitored to ensure accurate replication of 
the chromosomes just once per cell cycle and completion of the replication 
before the onset of mitosis. The sequence of events and the components of the 
DNA replication machinery are highly conserved throughout the entire 
eukaryotic world. After initiation of DNA replication in the S phase, the MCM 
complex moves away from replication origins as part of the DNA replication 
fork machinery. The MCM2~7, a ring-shaped hexameric complex, is the 
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replicative DNA helicase. This DNA unwinding helicase prepares the ground 
for the polymerases by melting and unwinding the DNA template and likewise 
removing the torsional stress ahead of the replication fork. Since a DNA 
polymerase can only extend an existing DNA strand paired with the parental 
strand, a short fragment of DNA or RNA, called primer, must be created and 
paired with the template strand before a DNA polymerase can synthesize a new 
daughter strand. A primase tightly associated with polymerase α (pol α) 
synthesizes a primer that serves as starting point for the associated pol α. On the 
leading strand, binding of the ring clamp PCNA on the primer-template 
terminus displaces pol α. The association of polymerase δ (pol δ) with PCNA 
stimulates its processivity, so that it can synthesize the remainder of the leading 
strand. DNA replication is believed to be continuous on the leading strand in 
contrast to the lagging strand where replication occurs in opposite direction of 
the replication forks. The lagging strand synthesis is carried out by the 
combined action of primase and pol α leading to the formation of so-called 
Okazaki fragments. The replication factor C (RFC) enhances the activity of pol 
α and finally a ligase is needed to close the remaining nicks on the lagging 
strand (Hübscher, 2009).  
 
 
Fig.2 Schematic model of leading and lagging strand synthesis 
Modified after: 
Geoffrey M Cooper 
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Since lagging strand synthesis occurs discontinuously and in opposite 
direction than replication fork progression, it cannot be replicated in its entirety. 
The end replication problem would lead to shortening of this strand at each cell 
cycle and therefore, the need for a special chromosomal region, the telomeres, is 
apparent. In human cells, the sequence of the telomeres consists of an AGGGTT 
repeat and a specialized enzyme, the telomerase prevents progressive shortening 
by adding this repeat to the ends of DNA molecules. The catalytic activity of 
this unusual enzyme polymerizes deoxyribonucleotides directed by its RNA 
template as well as the RNA template itself.  
Finally a complex of telomeric proteins, the Shelterin complex, 
consisting of TRF1, TRF2, Rap1, Tin2, Pot1 and TPP1, helps to protect the free 
DNA ends. This protective complex prevents the cells from recognizing this 
structure as a DNA double strand break (DSB), that otherwise would lead to a 
checkpoint activation and recruitment of DSB repair factors (Blasco, 2007). 
 
 
Fig.3 Schematic representation of Telomeres 
Modified after: 
Maria A Blasco 
Nature Chemical Biology 3, 640 - 649 (2007) 
 
1.1.4. DNA damage associated replication and repair 
 
DNA lesions generated by exogenous agents or endogenous processes 
are a constant threat for the genome.  Such lesions can cause stalling and 
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collapse of the replication fork and lead to chromosome lesions, mutations, 
genome rearrangements and eventually cancer (Hickson, 2003). To prevent this, 
a replication checkpoint has evolved as surveillance mechanism to control 
components of the replisome (Muzi-Falconi et al., 2003) and to allow 
coordinating replication with cell cycle progression and DNA repair. Besides 
the environmental factors such as radiation and mutagenic chemicals, copying 
errors are occasionally introduced by polymerases during DNA replication. The 
fidelity of DNA replication is being maintained by several distinct mechanisms, 
the first being the proofreading activity of the polymerases. If an incorrect base 
has been incorporated, this will cause pausing of the polymerase and its intrinsic 
exonucleolytic activity will then excise the misincorporated base and resume 
replication. Another mechanism that allows the removal of misincorporated 
bases that have not been detected and removed by the polymerase itself is 
mismatch repair. The mismatch repair machinery consisting of MutSα 
(Msh2/Msh6), primarily involved in base substitution and small loop mismatch 
repair, MutSβ (Msh2/Msh3), involved in small loop repair, in addition to large 
loop repair and MutLα (Mlh1/Pms2), is a strand specific system for recognizing 
and repairing misincorporated bases that can arise during DNA replication, for 
example. The hemimethylation pattern of newly synthesized daughter strands 
allows the mismatch repair system to excise the wrong incorporated base from 
the correct strand. Exo1 is the exonuclease that, upon recognition of the 
mismatch, excises the concerned region on the DNA in a 5’-3’ orientation. The 
different combinations of the MutS and MutL complexes confer additional 
repair features such as removing erroneous insertions or deletions, to this 
multifaceted system (Jiricny, 2006). 
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Fig.4 The mismatch repair machinery 
Modified after: 
Josef Jiricny 
Nature Reviews Molecular Cell Biology 7, 335-346 (May 2006) 
 
DNA damages such as bulky adducts or crosslinks, that typically arise as 
a consequence of UV irradiation or chemical exposure, cause stalling of the 
replication fork by physically blocking the polymerase. 
Some of the lesions that prevent the progression of the processive 
polymerases can be overcome by other damage specific polymerases. A 
growing class of DNA polymerases, numbered ζ to κ, seem to be devoted 
specifically to overcoming damage-induced replicational stress. These special 
polymerases take over temporarily from the blocked replicative DNA 
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polymerase, polδ and pol ε, and possibly from polα. These polymerases have 
more flexible base-pairing properties permitting translesion synthesis (TLS), 
with each polymerase conferring special properties to overcome each category 
of injury (Maga and Hübscher, 2008). 
Nucleotide excision repair (NER) is an important mechanism by which 
the cell can remove the vast majority of UV-induced DNA damage such as 
thymine dimers and 6-4-photoproducts. Xeroderma pigmentosum and 
Cockayne's syndrome are two severe human diseases that result from in-born 
genetic mutations of NER proteins. The NER enzymes recognize bulky 
distortions of the DNA double helix that leads to the removal of the lesion 
carrying short single-stranded DNA segment, likewise creating a single-strand 
DNA gap, which is subsequently filled in by an DNA polymerase, which uses 
the undamaged strand as a template (Hoeijmakers, 2009). 
The cellular mechanisms that are primarily responsible for removing 
small, non-helix-distorting base lesions such as oxidized bases, alkylated bases 
and deaminated bases from the genome, is called base excision repair (BER). 
First, a Glycosylase removes the damaged or inappropriate bases creating so-
called abasic sites (AP sites), and these are then cleaved by an AP 
endonuclease. Either short-patch BER can then process the generated single-
strand break, where a single nucleotide is replaced by combined action of a 
lyase and a polymerase or long-patch BER, where 2-10 new nucleotides are 
synthesized by a polymerase and the displaced strand is removed by a flap 
endonuclease before the remaining nick is closed by a ligase. 
X-rays, chemicals or replication of single-strand breaks (SSBs) and 
presumably during repair of interstrand crosslinks, DSBs can be induced. These 
are particularly dangerous lesions, since free DNA ends can cause chromosomal 
rearrangements and translocations that might lead to genome instability. DSBs 
are also problematic during mitosis as intact chromosomes are required for 
proper chromosome segregation during cell division (Hoeijmakers, 2001). 
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Fig.5 DNA damage and DNA repair pathways 
Modified after: 
Jan H. J. Hoeijemakers 
Nature 411, 366-374 (17 May 2001) 
 
Two different mechanisms address DSBs according to the cell cycle 
phase. During S and G2 phase of the cell cycle homologous recombination is 
the main pathway to repair these lesions and it is probably favoured because of 
the presence of the newly replicated sister chromatids, which provide a second 
copy of the sequence that can serve as template. During G1 phase of the cell 
cycle, when a second copy is not available, the error prone non-homologous end 
joining (NHEJ) is the main pathway to address DSBs (Downs et al. 2007) 
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Fig.6 DSB repair by NHEJ and homologous recombination 
Modified after: 
Jessica A. Downs, Michel C. Nussenzweig &  André Nussenzweig 
Nature 447, 951-958(21 June 2007) 
 
1.2. DNA damage response (DDR) 
1.2.1. General features of the DDR 
 
 
There are various, mostly negative outcomes of DNA damage. Acute 
consequences arise from disturbed DNA metabolism, triggering cell-cycle arrest 
or cell death. Long- term effects result from irreversible mutations contributing 
to oncogenesis. 
To counteract threats posed by DNA damage, cells have evolved 
mechanisms, collectively termed the DNA-damage response, in order to detect 
DNA lesions, signal their presence and promote their repair. Defects in these 
mechanisms generally render cells more sensitive towards DNA-damaging 
agents and are the cause of multiple human diseases. Although the DNA 
damage responses differ for the different classes of DNA lesions, they share 
many common general features. One key regulator of the DNA damage 
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response is the generation of ssDNA. Few DNA damaging agents introduce 
long ssDNA gaps themselves, but rather does the excision of a bulky adduct or 
other damages from the DNA template lead to these gaps. Replication stress 
also leads to an accumulation of ssDNA at the fork, but it remains unclear 
whether nucleases might participate to increase the gap size beyond a certain 
threshold that activates the DDR. The same holds true for DNA DSBs that do 
not contain any ssDNA per se. The generation of the structures needed for 
strand invasion and homology search requires the generation of 3’ ssDNA tails 
by an exonuclease (Zhou and Elledge 2000). The action of the nucleases leads 
to a DDR by activating the checkpoints. This activation occurs through a 
pathway initiated with RPA coating of the ssDNA gaps that, in turn, stimulate 
the binding of ATR-interacting protein (ATRIP). The latter is required for the 
recruitment of Ataxia-telangiectasia mutated- and Rad3-related (ATR) to sites 
of DNA damage and for ATR-mediated Chk1 activation in human cells (Zou 
and Elledge, 2003). 
 
 
Fig.7 Checkpoint activation in response to DSB’s and replication fork stalling 
Modified after: 
Zou and Elledge 
Science. 2003 Jun 6;300(5625):1542-8. 
 
To complete the DDR, ATR additionally phosphorylates substrates such 
as p53, Brca1 and Rad17 in response to these events. This cascade is highly 
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conserved, due to its central role in the DDR, which is highlighted by the fact 
that Ddc2, the yeast ATRIP homologue is recruited to the sites of RPA coated 
ssDNA in an RPA dependent manner, and the downstream effectors Mec1 
(ATR homologue; see table below for complete list of orthologous genes) and 
Chk1 lead to the same signalling cascade in yeast than in human cells (Zou and 
Elledge, 2003). 
 
 
Fig.8 Checkpoint signaling cascade in response to replication stress 
Modified after: 
Zhou and Ellegdge  
Nature. 2000 Nov 23;408(6811):433-9. 
 
1.2.2. Checkpoint kinases 
 
The DNA damage and DNA replication checkpoints are highly 
conserved cellular surveillance mechanisms permitting cells to maintain 
genome stability in response to genotoxic stresses. Upon detection of the 
damage, PIKKs (PI3-kinase like kinases Tel1 and Mec1 in Saccharomyces 
cerevisiae and ATM and ATR in mammals) carry out the initial transduction of 
the DNA damage signal. Phosphorylation of the downstream targets by the 
PIKKs facilitates physical protein interactions mediated by the phosphopeptide 
binding domains, FHA (forkhead-associated) and BRCT (Brca1 C terminus) 
that are found in numerous DNA damage-response proteins. Among such 
targets we find Rad9, Mrc1 as well as effector kinases such as Rad53. As a 
consequence of DNA damage or DNA replication stress, Chk1/Rad53 in S. 
cerevisiae and CHK1/CHK2 in mammals are phosphorylated by PIKKs. These 
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downstream effector kinases undergo autophosphorylation, where FHA 
domains mediate self-oligomerization and interactions with mediator proteins 
such as Rad9 and Mrc1, to become fully active. The formation of these PIKK 
dependent protein complexes is the juncture at which the DNA damage or 
replication stress is amplified (Zou and Elledge 2000).  
 
 
 
Fig.9 Checkpoint signaling and their downstream targets 
Modified after: 
Nyberg et al. 
Annual Review of Genetics Vol. 36: 617-656 
 
1.2.3. The DNA replication checkpoint 
 
The regulation of DNA replication by checkpoint controls is of key 
importance for the maintenance of genome stability and, potentially, in cancer 
therapy. Since fork collapse can lead to chromosome rearrangments, genome 
instability or cell death, the major role of checkpoint proteins may be to 
stabilize stalled replication forks. Replication forks slow or stall when they 
encounter DNA adducts that cause a physical block to the replication fork or 
when dNTP pools are limiting. Depletion of the nucleotide pool can be achieved 
by HU treatment, which causes stalling of the replication forks without inducing 
other damages such as DNA DSBs. Upon disruption of DNA replication, four 
cellular responses occur: Initiation of replication (origin firing) is blocked, 
elongation slows down, slowed or stalled replication forks are stabilized and 
entry into mitosis is blocked. In S. cerevisiae, the best-studied model organism, 
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checkpoint proteins regulate three of these four responses. After DNA damage, 
the key Mec1 and Rad53 regulators, prevent late origin firing, stabilize stalled 
replication intermediates and prevent entry into mitosis (Nyberg et al. 2002). 
Strikingly it remains unclear how slowing of the elongation process is achieved, 
but it is clear that slowing of elongation does not require the yeast checkpoint. 
We addressed this question in the study presented here and provide evidence 
that 14-3-3 proteins are central regulators of the events at stalled replication 
forks and are especially important for the regulation of the elongation kinetics. 
 
 
Fig.10 Events occurring at stalled replication forks 
Modified after: 
Nyberg et al. 
Annual Review of Genetics Vol. 36: 617-656 
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Orthologous DNA damage response proteins 
Protein function Mammals S. pombe S. cerevisiae 
Sensors 
RFC1-like Rad17 Rad17 Rad24 
PCNA-like Rad9 Rad9 Ddc1 
  Rad1 Rad1 Rad17 
  Hus1 Hus1 Mec3 
BRCT-containing BRCA1 Crb2/Rph9 Rad9 
  TopBP1 Cut5 Dpb11 
DSB recognition/repair Mre11 Rad32 Mre11 
  Rad50 Rad50 Rad50 
  Nbs1   Xrs2 
Replication proteins 
        recruits polymerases TopBP1 Cut5 Dpb11 
needed for replication   Drc1 Drc1 
DNA polymerase Pol2 Cdc20 Pol2 
DNA helicase BLM, WRN* Rhq1/Rad12 Sgs1 
Topoisomerase Top3 Top3 Top3 
clamp loader Rfc2–5 Rfc2–5 Rfc2–5 
binds ssDNA Rpa2   Rfa2 
Transducers 
PI3-kinases (PIKK) ATR Rad3 Mec1 
  ATM Tel1 Tel1 
PIKK binding partner ATRIP Rad26 Ddc2/Lcd1 
Effector Kinases Chk1 Chk1 Chk1 
  Chk2 Cds1 Rad53 
Replication fork — — Tof1 
stabilizers Claspin Mrc1 Mrc1 
*WRN—mutated in Werner syndrome. 
 
Table 1 List of DNA damage response proteins 
Modified after: 
Nyberg et al. 
Annual Review of Genetics Vol. 36: 617-656 
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1.3. DNA Nucleases 
1.3.1. General features of DNA nucleases 
 
Nucleases are enzymes capable of cleaving the phosphodiester bonds 
between nucleotide subunits of nucleic acids. These enzymes play crucial roles 
in various DNA repair processes, which involve DNA replication, base excision 
repair, nucleotide excision repair, mismatch repair, and double strand break 
repair. Nucleases can be further divided into endonucleases and exonucleases. 
There exist structure specific nucleases such as the flap endonucleases (FENs) 
and sequence specific nucleases such as the restriction nucleases.  
Endonucleases cleave the phosphodiester bond within a polynucleotide chain. 
Some DNA repair pathways require an incision as first step to grant access of 
other enzymes to free DNA ends, and this is followed by excision of the 
damaged structure. One such example is the structure specific endonuclease 
Mus81/Emi1 that cleaves branched DNA and was recently discovered to be a 
new fork/junction specific endonuclease. 
Restriction enzymes have evolved mainly to protect microorganisms 
against foreign DNA from invading viruses. These enzymes have the ability to 
recognise specific DNA sequences and to cut at a predefined position on this 
sequence. The host DNA remains protected as it undergoes methylation and 
likewise will not be recognised by the restriction enzyme as a target sequence. 
The HindII enzyme that originates from Haemophilus influenza and cleaves a 
specific sequence of six nucleotides always in the middle was the first isolated 
restriction enzyme and the starting point for the generation of highly useful 
tools for molecular biology (Tomlinson et al. 2010). 
 
1.3.2. Exonucleases 
 
Exonucleases have the ability to cleave nucleotides one at a time from 
the end of a polynucleotide chain. It is a hydrolyzing reaction that cleaves the 
phosphodiester bonds at the 3’ or 5’ end of DNA or RNA molecules. The 
diversity of Exonucleases is quite high and most of them are specialized to carry 
out one specific task. Although some nucleases can only act on the 3’ or 5’ end 
 24 
of a DNA or RNA molecule respectively, it is quite frequent the case of 
complementation of function when an Exonuclease is damaged or absent. These 
backup Exonucleases usually carry out the reaction with much lower efficiency 
than the specialized enzyme but their partial redundancy is usually sufficient to 
prevent any deleterious effects on cell viability or genomic stability. 
Maintenance of stable replication intermediates when DNA synthesis is 
impeded requires regulation of several factors, among these, nucleases require 
particularly fine-tuning (Tran et al. 2004). 
 
 
1.3.2.1. Exonuclease 1 (Exo1) 
 
Exo1 is a Rad2 family DNA repair nuclease that was originally 
identified in the fission yeast Schizosaccharomyces pombe (Szankasi et al., 
1992 and 1995). In vitro, Exo1 was shown to be a structure specific nuclease, 
which possesses 5’-3’ exonuclease and 5’ flap endonuclease activity (Lieber, 
1997). It is highly conserved throughout the eukaryotic domain and the human 
EXO1 gene encodes a protein bearing only 27% identity to its yeast counterpart 
(Tishkoff et al., 1998). Nevertheless, hEXO1 was shown to complement 
phenotypes conferred by the deletions of Saccharomyces cerevisiae EXO1 and 
RAD27 (Qui et al., 1999) showing that at least certain central aspects of Exo1 
function seem to be conserved. 
Exo1 catalyzes the removal of mononucleotides from the 5’ end of the 
DNA duplex, showing a strong preference for blunt-ended, 5’-recessed termini 
and DNA nicks (Lee et al., 1999). The exonucleolytic activity of the enzyme is 
more efficient on double-stranded DNA (dsDNA) than on single-stranded DNA 
(ssDNA) (Lee et al., 1999). 
Exo1 is implicated in several DNA repair pathways including mismatch 
repair (MMR), post replication repair, meiotic and mitotic recombination 
(Fiorentini et al., 1997) (Kirkpatrick et al., 2000) (Tsubouchi and Ogawa, 2000).  
The fact that Exo1 is involved in mutation avoidance is due to its role in 
MMR that has been well characterized. Initially, yeast Exo1 was reported to 
interact with yeast Msh2 (Tishkoff et al., 1997), an interaction that was also 
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confirmed for their mammalian counterparts (Schmutte at al., 2001). Mlh1 is 
another central component of the MMR machinery that was reported in the 
literature (Schmutte at al., 2001) and confirmed in our yeast two-hybrid screen 
to interact with Exo1 (see Results, Table 1). Genetic studies demonstrated that 
Exo1 functions catalytically during MMR (Sokolsky et al., 2000).  More recent 
genetic studies have suggested a catalytic as well as structural role for Exo1 in 
MMR (Tran et al. 2002). The genetic analyses did not always provide a clear 
answer to the question if Exo1 is an essential component of MMR. This is 
probably due to the redundant role of Exo1 to several other nucleases, and 
maybe even to the redundancy to the exonuclease activity of certain 
polymerases (Tran et al., 2004). After recognition of a mismatch and the 
recruitment of all the components of the MMR machinery, Exo1 carries out the 
excision step that removes the mismatch, thus creating an ssDNA stretch that 
will serve as a platform for the DNA polymerase. After resynthesis of the 
excised stretch a ligase will close the remaining nick and likewise complete the 
MMR (Jiricny 2006). 
 
Fig.11 Exo1 plays a structural as well as functional role in MMR 
Modified after: 
Alberto Martin &  Matthew D. Scharff 
Nature Reviews Immunology 2, 605-614 (August 2002) 
 
Recent studies have shown that Exo1 is the exonuclease responsible for 
the processive resection of double strand breaks (DSBs) to generate structures 
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suitable for homologous recombination (HR) (Zhu et al., 2008). Upon creation 
of short ssDNA overhangs (end-trimming) by MRE11, a component of the 
MRN complex (MRX in yeast), Ctip (Sae2 in yeast) promotes DNA end 
resection (Sartori et al. 2007). The end resection is carried out by Exo1, which 
generates long 3’ single stranded tails from the previously created short ssDNA 
overhangs. These are the required substrates for binding of the Rad51 
recombinase to initiate the homology search and strand invasion steps of 
recombination (Mimitou and Symington, 2009) and for Rad52-mediated 
annealing (Mimitou and Symington, 2008). 
 
 
Fig.12 DSB processing by Exo1 
Modified after: 
Mimitou and Symington 
Nature 455, 770-774 (9 October 2008) 
 
The generation of ssDNA is also activating the DNA damage response 
and likewise leads to a cell cycle arrest in response to DNA damage (Zou and 
Elledge, 2003). This, in turn, implicates that the regulation of the exonuclease 
activity of Exo1 is crucial for the control of the checkpoint activation and will 
reflect on the modulation of the DDR (Morin et al. 2008) 
Several lines of evidence suggest that Exo1 plays a crucial role at the 
replication fork. 
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Budding yeast Exo1 was previously demonstrated to act redundantly 
with Rad27 in processing Okazaki fragments during DNA replication (Qui et 
al., 1999, Tran et al. 2002). More recently, Exo1 was shown to be recruited to 
stalled replication forks where it counteracts fork reversal through the resection 
of newly synthesized strands and the resolution of the sister chromatid junctions 
(Cotta-Ramusino et al., 2005).  
 
Fig.13 Exo1 processes stalled replication forks and counteracts fork reversal 
Modified after: 
Cotta-Ramusino 
Molecular Cell, Vol. 17, 153–159, January 7, 2005 
 
In mammalian cells, EXO1 activity is controlled by post-translational 
modifications, with ATR-dependent phosphorylation targeting it to ubiquitin-
mediated degradation upon replication fork stalling (El-Shemerly et al., 2005; 
El-Shemerly et al., 2007), and ATM-dependent phosphorylation apparently 
restraining its activity to favour RAD51 loading during homologous 
recombination (Bolderson et al. 2009). Analogously, Mec1-dependent 
phosphorylation of yeast Exo1 was recently shown to down regulate its activity 
at uncapped telomeres (Morin et al. 2008). This combined evidence highlights 
the concept that Exo1 nucleolytic activity is tightly controlled under DNA 
replication stress and other cellular responses to DNA damage. Substantiating 
this idea, studies in budding yeast showed that EXO1 deletion suppresses the 
sensitivity of rad53 mutant cells to genotoxic agents that cause reversible or 
irreversible stalling of the replication forks (Segurado and Diffley 2008), and 
this suppression was demonstrated to depend on the loss of Exo1 nuclease 
activity. Interestingly, deletion of EXO1 is able to suppress the genotoxic 
sensitivity caused by loss of Rad53 function, but not the one ascribed to 
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mutations in the upstream kinase Mec1, indicating separable roles in replication 
fork stabilization for these two kinases (Segurado and Diffley 2008). 
 
 
1.4. 14-3-3 Proteins 
 
 The highly conserved eukaryotic 14-3-3 protein family establishes 
phosphorylation-dependent interactions and modulates the function of proteins 
involved in processes such as metabolism, protein trafficking, signal 
transduction, apoptosis and cell-cycle (Gardino, 2006; Morrison 2009). 
Although several phosphospecific-binding domains are known, the 14-3-3 
proteins usually recognize their target proteins in a specific manner via a 
discrete phosphoserine or phosphotreonine motif. The two consensus motifs are 
RSXpS/pTXP and RXXXpS/pTXP, where R is argenine, S is serine, P is 
proline, X is any amino acid and pS/pT is phosphoserine or phosphothreonine, 
respectively (Muslin et al., 1996). In addition to the peptide binding groove, 
other regions of the 14-3-3 surface can determine substrate binding specificity 
(Wilker et al., 2005). Nevertheless, also “imperfect” sites may be sufficient to 
bind to the 14-3-3 dimer and phosphoindependent interactions, which do not 
require the above mentioned consensus sequence, have additionally been 
reported (Bridges and Moorhead 2005). 14-3-3’s are very abundant, small 30 
kDa acidic proteins that are expressed in all eukaryotic cells and tissues. Their 
name is due to their elution and migration pattern on two-dimensional DEAE-
cellulose chromatography and starch gel electrophoresis (Aitken 2006). Seven 
14-3-3 isoforms exist in mammalian cells - β, γ, ε, σ, ζ, τ, η, but only two in 
unicellular organisms such as yeast. In Saccharomyces cerevisiae, there are two 
isoforms, the major isoform Bmh1 (Brain Modulosignaling Homologue 1) and 
the minor isoform Bmh2. Structural analysis showed that 14-3-3 proteins self-
assemble into flexible homo- and hetero-dimers that form a central groove able 
to adapt two extended peptides of varying size (Xiao 1995; Gardino, 2006). 
This feature confers them the ability to act as adaptor proteins that integrate 
signals from different pathways (Braselmann 1996; Bridges and Moorhead 
2005). 14-3-3 proteins can exert structural effects on their target proteins. As 
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depicted on panel A below, 14-3-3 proteins can induce conformational changes 
to their target proteins upon binding. 14-3-3 binding can also result in the 
occlusion of a specific region on the target and likewise mask for example an 
active site as it is shown in panel B. And finally, as shown in panel C, binding 
of 14-3-3 proteins can lead to the colocalization of two proteins, where the 14-
3-3 dimer acts as a docking platform (Bridges and Moorhead 2005). 
 
 
Fig. 14 14-3-3 proteins act as a docking platform 
Modified after: 
Bridges and Moorhead 
Sci. STKE, 9 August 2005 
 
 14-3-3 proteins can bind cruciform DNA, a structure that was shown to 
form at yeast origins of replication (Yahyaoui et al., 2007), and are able to 
associate with replication initiation proteins such as Mcm2 and Orc2 (Yahyaoui 
2009). 
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Fig.15 14-3-3 Proteins can bind cruciform DNA 
Modified after: 
Hadjopoulos 
TiBS, Volume 33, Issue 1, January 2008, Pages 44-50 
 
Upon DNA damage and DNA replication stress, 14-3-3 proteins are 
required for cell cycle restart, suppression of genomic instability and viability 
(Lottersberger et al., 2003). Moreover, 14-3-3 proteins genetically and 
physically interact with the checkpoint protein Rad53 and genetically with the 
checkpoint kinase Dun1. The physical interaction with Rad53 only occurs in the 
presence of the DNA damaging agent MMS (Methyl methanesulfonate). 14-3-3 
proteins directly facilitate Rad53 function in vivo by stabilizing an active form 
of the kinase (Usui and Petrini, 2007). These interactions may be an explanation 
for the previously observed checkpoint defects in 14-3-3 mutant yeast cells 
(Lottersberger et al. 2003). The yeast 14-3-3 proteins were also shown to 
interact with the acetyltransferases and deacetylases Esa1 and Rpd3 upon 
replication perturbations (Lottersberger et al., 2007). Taken together, these data 
point to an important role of 14-3-3 during replication stress, though their exact 
mechanism of action remains unknown.  
 31 
2. RESULTS 
 
2.1.        14-3-3 Proteins Regulate Exonuclease 1-Dependent Processing Of 
Stalled Replication Forks 
 
 
 
Kim Engels, Michele Giannattasio, Marco Muzi-Falconi, Massimo Lopes and 
Stefano Ferrari 
 
 
(manuscript submitted to PLOS genetics) 
 
 
 
This manuscript describes a novel function of 14-3-3 proteins during 
replication stress. Our work identifies 14-3-3 proteins as novel interaction 
partner of Exonuclease1, an enzyme with an increasingly important role in 
DNA metabolism, recently claimed to participate in the onset of genome 
instability. 14-3-3 proteins were also previously shown to play a role in 
protecting genome stability, although the underlying mechanism had escaped 
identification. This manuscript describes an unprecedented link in the field, 
showing that an evolutionarily conserved pathway through which 14-3-3 
proteins maintain genome integrity after replication stress relies on the control 
of Exo1 activity at stalled replication forks. Additionally this manuscript 
provides evidence for the control of replication fork progression under limiting 
nucleotide concentrations by 14-3-3 proteins, and poses them as central 
regulators of events at stalled replication forks. 
 
I contributed to this study by designing and performing the research and 
by writing the manuscript. 
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ABSTRACT 
 
Replication fork integrity, which is essential for the maintenance of genome 
stability, is monitored by checkpoint-mediated phosphorylation events. 14-3-3 
proteins are able to bind phosphorylated proteins and were shown to play an 
undefined role under DNA replication stress. Exonuclease 1 (Exo1) processes 
stalled replication forks in checkpoint-defective yeast cells. We now identify 
14-3-3 proteins as in vivo interaction partners of Exo1, both in yeast and 
mammalian cells. Yeast 14-3-3-deficient cells fail to induce Mec1-dependent 
Exo1 hyperphosphorylation and accumulate Exo1-dependent ssDNA gaps at 
stalled forks, as revealed by electron microscopy. This leads to persistent 
checkpoint activation and exacerbated recovery defects. Moreover, using DNA 
bi-dimensional electrophoresis we show that 14-3-3 promote fork progression 
under limiting nucleotide concentrations. We propose that 14-3-3 proteins assist 
checkpoint-mediated phosphorylation of Exo1 and additional unknown targets, 
promoting fork progression, stability and restart in response to DNA replication 
stress. 
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INTRODUCTION 
 
DNA lesions can cause stalling and collapse of the replication fork and lead to 
chromosome breaks, mutations, genome rearrangements and eventually cancer 
(Branzei and Foiani 2010). To prevent this, a replication checkpoint has evolved 
as surveillance mechanism to control components of the replisome (Muzi-
Falconi et al. 2003) and to allow coordinating replication with cell cycle 
progression and DNA repair. Maintenance of stable replication intermediates 
when DNA synthesis is impeded requires regulation of several factors. Among 
these, nucleases require particularly fine-tuning. 
 
Exo1 is a Rad2 family DNA repair nuclease able to remove mononucleotides 
from the 5’ end of the DNA duplex (Lee and Wilson 1999) that was originally 
identified in the S. pombe (Szankasi and Smith 1992) and subsequently in 
humans (Tishkoff et al. 1998). Exo1 is implicated in several DNA repair 
pathways including mismatch repair, post replication repair, meiotic and mitotic 
recombination and double strand breaks repair (Szankasi and Smith 1995; 
Fiorentini et al. 1997; Kirkpatrick et al. 2000; Tsubouchi and Ogawa 2000; 
Mimitou and Symington 2009). S. cerevisiae Exo1 acts redundantly with Rad27 
in processing Okazaki fragments during DNA replication (Qiu et al. 1999). 
More recently, Exo1 was shown to be recruited to stalled replication forks 
where it counteracts fork reversal (Cotta-Ramusino et al. 2005). Human EXO1 
activity is controlled by post-translational modifications, with ATR-dependent 
phosphorylation targeting it to ubiquitin-mediated degradation upon replication 
fork stalling (El-Shemerly et al. 2005; El-Shemerly et al. 2008), and ATM-
dependent phosphorylation apparently restraining its activity during 
homologous recombination (Bolderson et al. 2010). Analogously, Mec1-
dependent phosphorylation inhibits yeast Exo1 activity at uncapped telomeres 
(Morin et al. 2008). Studies in budding yeast showed that EXO1 deletion 
suppresses the sensitivity of rad53, but not mec1, mutant cells to agents causing 
reversible or irreversible stalling of replication forks (Segurado and Diffley 
2008). Taken together, this evidence indicates that Exo1 activity is tightly 
controlled under DNA replication stress and DNA damage. 
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Eukaryotic 14-3-3 are highly conserved proteins that establish phosphorylation-
dependent interactions and modulate the functions of proteins involved in 
processes such as metabolism, protein trafficking, signal transduction, apoptosis 
and cell-cycle (Morrison 2009). Seven 14-3-3 isoforms exist in mammalian 
cells, but only two in yeast. Structural analysis showed that 14-3-3 proteins self-
assemble into flexible homo- and hetero-dimers forming a central groove that is 
able to adapt two extended peptides (Xiao et al. 1995; Gardino et al. 2006). This 
feature confers them the ability to act as adaptors that integrate signals from 
different pathways (Braselmann and McCormick 1995; Bridges and Moorhead 
2005). 14-3-3 proteins can also bind cruciform DNA (Yahyaoui et al. 2007) and 
replication initiation proteins such as Mcm2 and Orc2 (Yahyaoui and Zannis-
Hadjopoulos 2009). Upon DNA damage and DNA replication stress, 14-3-3 
proteins are required for cell cycle restart, suppression of genomic instability 
and viability (Lottersberger et al. 2003). Moreover, 14-3-3 proteins genetically 
and physically interact with the checkpoint protein Rad53 (Usui and Petrini 
2007) as well as the acetyltransferases and deacetylases Esa1 and Rpd3 upon 
replication perturbations (Lottersberger et al. 2007). Although these data point 
to an important role of 14-3-3 during replication stress, the exact mechanism of 
14-3-3 action remains unknown.  
 
In this study, we identify 14-3-3 as novel interaction partners of Exo1 and 
demonstrate that they regulate phosphorylation of the nuclease. We provide 
evidence for an accumulation of Exo1-dependent ssDNA gaps at stalled forks in 
yeast 14-3-3 deficient cells and we show that this causes persistent checkpoint 
activation and recovery defects. We also show that 14-3-3 proteins control 
progression and stability of replication forks under conditions of limiting 
nucleotide availability. Taken together, our data demonstrate that 14-3-3 have a 
crucial role in regulating the function of proteins at stalled forks, among which 
Exo1 is a key target. 
 36 
RESULTS AND DISCUSSION 
 
14-3-3 proteins interact with EXO1 
To identify novel interaction partners for human EXO1 we designed a yeast 
two-hybrid screen with GAL4-bait fusion proteins that contain either full-length 
EXO1 or DN-EXO1 (EXO1366-846), which lacks the entire catalytic domain. 
Since the former was not expressed (data not shown), we used the latter to 
screen a blood peripheral cDNA library. Three 14-3-3 proteins were the highest 
hits (Supplemental Table 1), with the b- being more represented than the e- and 
z-isoform. The presence of an established EXO1 binding protein among the 
hits, MLH1 (Supplemental Table 1), confirmed the reliability of this screen.  
To independently verify these data, we performed co-immunoprecipitation 
experiments. Given the low abundance of EXO1 in the cell (El-Shemerly et al. 
2005), we transiently transfected HEK-293 cells with an Omni-tagged EXO1 
construct (El-Shemerly et al. 2005) and immunoprecipitated the expressed 
protein using a pan-14-3-3 antibody. The data showed that Omni-EXO1 and 14-
3-3 proteins could be recovered as a complex (Fig. 1A).  
To assess the physiological significance of the EXO1/14-3-3 interaction we 
selected S. cerevisiae, a system where only two 14-3-3 proteins are present, 
namely Bmh1 and Bmh2. In preliminary experiments we examined whether 
yeast Exo1 and 14-3-3 proteins interact. A C-terminal Myc- or a HA-tag was 
added to the endogenous EXO1 or BMH1/BMH2 genes, respectively. 
Immunoprecipitation experiments showed that Exo1 formed complexes with 
Bmh1 or Bmh2 in a HU-dependent manner (Fig. 1B). 
Taken together, these data suggest that the EXO1/14-3-3 interaction is 
conserved from yeast to mammalian cells. While the interaction is HU-
independent in mammalian cells, it requires HU in yeast. This may reflect the 
different modes of EXO1 regulation in the two systems (El-Shemerly et al. 
2008; Morin et al. 2008). 
 
14-3-3 deficient cells cannot restart stalled replication forks, but their 
recovery defect is partially suppressed by EXO1 deletion 
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Genetic and flow cytometric analysis evidenced the sensitivity of 14-3-3-
deficient cells to DNA replication stress, with distinct bmh1 (bmh2D) alleles 
showing different defects upon nucleotide depletion (HU) or treatment with 
DNA damaging agents (UV or methylmethansulfonate, MMS) (Lottersberger et 
al. 2003). However, despite the evidence that 14-3-3 proteins bind origins of 
replication and cruciform DNA (Alvarez et al. 2002), suggesting a regulatory 
role in DNA replication (Yahyaoui and Zannis-Hadjopoulos 2009), the issue of 
possible direct involvement of 14-3-3 in fork stability or processing under 
genotoxic stress conditions remained to be clarified. Given the comprehensive 
molecular characterization of yeast Exo1 as component of the replisome and of 
its role, in checkpoint defective cells, in the processing of forks stalled by 
nucleotide depletion (Cotta-Ramusino et al. 2005), we focused on the bmh1-280 
bmh2D allele (bmh1bmh2 hereafter), which shows normal cell cycle 
progression in unperturbed conditions, but selective sensitivity and cell cycle 
recovery defects in response to HU (Lottersberger et al. 2003). We thus asked 
whether these defects reflect a direct role of 14-3-3 proteins at replication forks 
and whether Exo1 is also implicated in these processes. We performed neutral-
neutral bidimensional gel electrophoresis (2D gel) on the early origin of 
replication ARS305 - known to be activated in HU-treated cells (Lopes et al. 
2001) - and observed that replication forks were still present close to the origin 
in bmh1bmh2 cells 60 min after HU removal (Fig. 2A). Thus, although the 2D 
gel pattern looked normal in these cells, their forks failed to resume DNA 
synthesis, suggesting that misregulation of the replisome, without dramatic 
physical processing of the forks, might be sufficient to prevent fork restart. This 
effect was not detectably suppressed by EXO1 deletion (Fig. 2A).  
Flow cytometric analysis of HU-released cells confirmed the slow recovery of 
the bmh1bmh2 strain and showed that lack of Exo1 per se did not alter the 
pattern of cell cycle progression (Fig. 2B). On the other hand, EXO1 deletion in 
a bmh1bmh2 background led to a partial rescue of the recovery defect, 
particularly evident 120 min after release from HU (Fig. 2B). This evidence 
prompted us to ask whether EXO1 deletion in this background may affect 
Rad53 activity. Western blot analysis showed that, compared to wild type cells, 
Rad53 was hyperphosphorylated in HU-treated bmh1bmh2 cells and that its 
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dephosphorylation was retarded during the HU-recovery phase (Fig. 2C), thus 
correlating with the described replication restart defect. Importantly, deletion of 
EXO1 in 14-3-3-deficient cells re-established to a great extent the pattern of 
rapid Rad53 dephosphorylation in the recovery phase (Fig. 2C), substantiating 
the flow cytometry data (Fig. 2B). Overall these data suggest that 14-3-3 
proteins are directly implicated in the effective restart of stalled DNA 
replication forks. In their absence, Exo1 activity does not directly impact the 
rate of fork restart, but contributes to induce slow checkpoint inactivation and 
impaired cell cycle resumption.  
 
Reversible Exo1 phosphorylation in response to HU is dependent on 14-3-3 
proteins 
Exo1 is controlled in a phosphorylation-dependent manner upon replication fork 
stalling in mammalian cells (El-Shemerly et al. 2005) and upon a variety of 
genotoxic insults in yeast (Morin et al. 2008). We obtained evidence that yeast 
Exo1 is phosphorylated in a Mec1-dependent manner also in response to HU 
(Fig. 3A). Notably, the improved resolution of Exo1 phospho-forms over 
previously published work allowed us visualizing the complete pattern of Exo1 
phosphorylation in response to replicative stress (Fig. 3A and 3B). 
Next, we asked whether 14-3-3 proteins might be involved in the regulation of 
Exo1 phosphorylation. Western blot analysis showed that in 14-3-3-deficient 
cells Exo1 was not phosphorylated to the same stoichiometry observed in wild 
type cells (Fig. 3B, 90 min). Moreover, the rate of Exo1 dephosphorylation 
upon recovery from HU was considerably reduced in mutant cells, with Exo1 
being completely dephosphorylated in wild type but not in 14-3-3-deficient 
cells (Fig. 3B, 120 min). Defective Exo1 phosphorylation in HU-treated 14-3-3-
deficient cells is not an indirect consequence of defective checkpoint activation, 
as under these conditions Rad53, another Mec1-dependent checkpoint target, is 
promptly phosphorylated (Fig. 2C). Since phosphorylation restrains yeast Exo1 
activity (Morin et al. 2008), we propose that 14-3-3 proteins play an important 
role in the dynamic control of Exo1 activity upon DNA replication stress and 
may act as platform for Exo1 phosphorylation to take place.  
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Exo1 is responsible for the accumulation of ssDNA gaps behind the fork in 
bmh1bmh2 cells 
As Exo1 activity and Rad53 phosphorylation have been linked to the processing 
of stalled DNA replication forks, we decided to assess whether defective Rad53 
and Exo1 phosphorylation in 14-3-3-deficient cells could reflect changes in the 
fine architecture of stalled forks. To answer this question, we synchronized the 
cells in G1, released them for 1h in YPD medium containing 0.2 M HU and 
examined replication intermediates by electron microscopy (EM) under non-
denaturing conditions (Lopes 2009). For each strain, about 100 replication 
intermediates were analyzed in duplicate. 14-3-3-deficient cells showed a 
dramatic accumulation of ssDNA gaps behind the replication fork (Fig. 4A). 
Statistical analysis indicated that approximately 50% of all replication 
intermediates analyzed contained one or more ssDNA gaps (Fig. 4B). 
Interestingly, deletion of EXO1 in the bmh1bmh2 background completely 
suppressed this phenotype, leading to a reduction of the ssDNA gaps behind the 
fork to a level similar to wild type or exo1Δ cells  (Fig. 4B). The comparison of 
ssDNA gaps length scored by EM evidenced a striking difference: whereas 
bmh1bmh2 cells displayed a significant number of large size gaps (>0.5 Kb), 
the latter were absent in bmh1bmh2 exo1Δ cells (Fig. 4C). These data suggest 
that 14-3-3 proteins are required to prevent unscheduled Exo1 activity behind 
stalled replication forks in a checkpoint-proficient background. The 
implications of these observations are of great significance. Since Exo1 is a 5'-3' 
exonuclease, a loose control of its activity may render DNA synthesis more 
discontinuous in conditions of replicative stress. Although additional work is 
required to directly address this point, it is conceivable that continuous 
polymerase stall due to insufficient deoxynucleotide levels might lead to 
increased repriming events, thus raising the number of 5'-ends available for 
processing by Exo1. In this setting, a strict control of Exo1 activity would be 
needed to limit damage. The resolution limit of 50-70 nucleotides may have 
impaired detection of nicks/small gaps in this as well as in previous EM studies 
with HU (Sogo et al. 2002). Such structures, however, become visible in 14-3-
3-deficient cells, where the unleashed Exo1 activity would enlarge gaps above 
the detection limit. 
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Defective fork progression in 14-3-3 defective cells is independent on EXO1 
Replication recovery defects have been previously described and usually reflect 
replication fork collapse detectable by 2D gel analysis (Lopes et al. 2001). On 
the contrary, stalled replication forks in 14-3-3 deficient cells, albeit unable to 
restart DNA synthesis and abnormally processed by Exo1 activity, upon 
prolonged HU treatment show a 2D gel pattern indistinguishable from that of 
wild type cells. We thus decided to investigate in more detail the structure and 
progression of these forks, performing 2D gel analysis at different time points 
after HU addition. To this end, cells synchronized in G1 by a-factor were 
released into medium containing HU and replication intermediates were 
examined by 2D gels. Fig. 5B shows the probes designed to visualize 
replication fork progression in a region of Chromosome III that contains, 
besides the early active origin ARS305 (Newlon and Theis 1993), a contiguous 
passively replicated region (Part A) and a region including the dormant origin 
ARS301 (Part D) (Lopes et al. 2001). As compared to wild type, bmh1bmh2 
cells showed the same kinetics of origin firing, albeit with slightly lower 
efficiency as revealed by the intensity of the bubble arc at 30 min (Fig. 5C). 
Progression of the forks in HU from ARS305 across the region of Part A (~5 
Kb to the left of ARS305) was completed after 2-3h in wild type cells, with the 
peak of intermediates detectable after ~1h. In bmh1bmh2 cells the first 
intermediates appeared on this region with 30 min delay, whereas the peak of 
intermediates was delayed of ~2h as compared to wild type cells (Fig. 5C), 
indicative of a significant decrease in the rate of the replication fork progression 
in HU. 
It was previously shown that yeast 14-3-3 proteins bind to the checkpoint kinase 
Rad53 and directly influence its DNA damage-dependent functions (Usui and 
Petrini 2007). Therefore, we asked whether the slow fork progression in 
bmh1bmh2 cells might be solely due to checkpoint defects. To address this 
issue, we used checkpoint defective Rad53-mutant cells (rad53-K227A). The 
latter displayed striking differences when compared to bmh1bmh2 cells. Both 
the destabilization of replication intermediates (ARS305 and Part A) and the 
uncontrolled firing of dormant origins displayed by rad53-K227A cells (Part D) 
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(Lopes et al. 2001), were absent in bmh1bmh2 cells (Fig. 5C). Furthermore, 
electron microscopy did not display any fork reversal or accumulation of 
ssDNA at replication forks, typical of HU-treated rad53 cells (Sogo et al. 2002) 
(data not shown). Finally, drop assays (Supplemental Fig. S1) and 2D gel 
analysis (Supplemental Fig. S2C, F and H) revealed synergistic effects of 14-3-
3 and Rad53 on both survival and fork stability. Overall, these data indicate that 
the phenotype observed in 14-3-3 deficient cells reflects a genuine role of 14-3-
3 proteins at replication forks and that 14-3-3 and Rad53 have crucial but 
distinct roles at HU-challenged forks.  
Deletion of EXO1 partially rescued the HU-sensitivity of rad53-K227A cells, 
but not of a bmh1 bmh2 strain (Supplemental Fig. S1). Furthermore, in contrast 
to checkpoint defective cells, where stability of replication intermediates could 
be rescued by EXO1 deletion (Cotta-Ramusino et al. 2005), fork progression 
defects of bmh1bmh2 cells were not rescued by loss of EXO1 (Supplemental 
Fig. S2G). Thus, while the processing defect that leads to accumulation of 
ssDNA gaps in 14-3-3-deficient cells was completely suppressed by EXO1 
deletion, this did not reflect in suppression of HU sensitivity nor of defective 
fork progression in HU-treated 14-3-3 deficient cells. Altogether this evidence 
suggests that 14-3-3 proteins might regulate additional targets during replication 
stress, possibly through modulation of their phosphorylation. This is not 
unexpected, given the role of 14-3-3 as integrators of signalling pathways 
(Morrison 2009) and considering the multiplicity of 14-3-3 targets (Jin et al. 
2004; Pozuelo Rubio et al. 2004). Our data implicate 14-3-3 proteins as possible 
central regulator of the checkpoint response. In analogy with previously 
reported cases (Braselmann and McCormick 1995) and according to structural 
data on the dynamic nature of 14-3-3 dimers (Yang et al. 2006), one may 
envisage a role for 14-3-3 proteins as docking clamp tethering Exo1 -and other 
unknown targets - with the kinase controlling its/their activity. Notably, 14-3-3 
proteins were reported to bind Rad53 (Usui and Petrini 2007), one of the 
candidate checkpoint kinases required for Exo1 phosphorylation (Morin et al. 
2008). 
In conclusion, this work sheds further light on processes occurring at stalled 
replication forks, proposing 14-3-3 proteins as central integrators of signals that 
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regulate fork stability and processing. Challenges lying ahead consist in the 
identification of components of the replisome, or proteins controlling them, that 
may be 14-3-3 targets, as well as in the elucidation of the exact mechanism by 
which 14-3-3 modulate Exo1 activity. 
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MATERIALS AND METHODS 
 
Saccharomyces cerevisiae strains and cell culture  
The yeast strains used in this study are isogenic to W303 and are listed in 
Supplemental Material. HEK-293 cells were maintained and transiently 
transfected as described (El-Shemerly et al. 2005). 
 
Yeast two-hybrid screen 
The yeast two-hybrid screening was performed with DN-EXO1 (EXO1366-846) as 
bait on a cDNA library generated from human peripheral blood mRNA (a kind 
gift of I. Stagljar, Toronto, Canada) as described previously (Jiao et al. 2004) 
and using THY AP4 as reporter strain. 
 
Western Blotting, Immunoprecipitation 
To visualize Exo1, an optimized Phos-tag system (5 mM Phos-tag reagent) was 
employed according to (Kinoshita et al. 2008). Proteins were transferred to 
nitrocellulose (porablot NCP, 0.45 µm pore size, Machery-Nagel) overnight at 
room temperature applying constant amperage (200 mA). Additional 
information about protein extraction and immunoprecipitation can be found in 
Supplemental Material. 
 
2D Gel Electrophoresis and Electron Microscopy 
DNA extraction with the CTAB method and neutral-neutral two-dimensional 
gel electrophoresis were performed as described (Lopes et al. 2003). Replication 
intermediates quantification (Lopes et al. 2001) and EM analysis (Lopes 2009) 
were performed as described. 
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FIGURE LEGENDS 
 
Figure 1 - EXO1 interacts with 14-3-3 proteins  
(A) HEK-293 cells were transiently transfected with empty vector (-) or 
pcDNA3.1-Omni-EXO1. Whole cell extracts (WCE, 2.5 mg) were 
immunoprecipitated with a pan-14-3-3 antibody and proteins were detected as 
indicated. Input = 50 mg WCE (B) Control yeast culture (wt) or cultures 
expressing Bmh1-HA Exo1-Myc (1) or Bmh2-HA Exo1-Myc (2) were treated 
for 3 h with 150 mM HU. WCE (10mg) were immunoprecipitated with the 
monoclonal antibody to HA and proteins were detected as indicated. CNTL = 
immunoprecipitation performed in the absence of the antibody. Input = 100 mg 
WCE. 
 
Figure 2 - Pattern of HU recovery in wild type, exo1, bmh1-280 bmh2Δ 
 and bmh1-280 bmh2Δ exo1Δ strains 
 (A) Representative 2D gels of RI at ARS305 analyzed 1h upon release from 
HU. (B) Time-course flow cytometric analysis of the DNA content in the 
indicated strains upon recovery from a HU-arrest. (C) Western blot analysis of 
Rad53 phosphorylation in HU-arrested cells and during the recovery phase.  
 
Figure 3 - Phosphorylation pattern of Exo1 in response to HU in wild type, 
mec1D, and bmh1-280 bmh2Δ strains 
(A) Western blot analysis of Exo1 phosphorylation in HU-arrested cells of the 
indicated strains. (B) Western blot analysis of Exo1 phosphorylation in HU-
arrested cells and during the recovery phase of the indicated strains. 
 
Figure 4 - Exo1-dependent generation of ssDNA gaps in bmh1 bmh2 
mutant cells 
(A) Representative replication intermediates visualized by electron microscopy 
in bmh1bmh2 cells released synchronously from G1 phase in HU 0.2 M for 1h: 
the magnified inset (asterisk) shows a representative ssDNA gap located behind 
the replication fork. Black arrows: ssDNA gap at the fork; White arrows: 
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internal ssDNA gap located behind the fork. (B) (C) Statistical analysis of 
ssDNA gaps number and length.  
 
Figure 5 - 2D gel analysis of replication intermediates from wild type, 
bmh1-280 bmh2Δ and rad53-K227A strains 
(A) Schematic representation of replication intermediates visualized by 2D gel 
electrophoresis. (B) Chromosome III region adjacent to ARS305 with indication 
of the probes used in 2D gel analysis. (C) Time-course resolution of replication 
intermediates obtained from the indicated strains grown in the presence of 0.2 
M HU. 
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2.2. Yeast two-hybrid screen identifies several novel human Exo1 
interaction partners 
 
To identify novel interaction partners for human EXO1 we performed a 
yeast two-hybrid screen. To this end, we constructed LexA-bait fusion proteins 
containing either full-length EXO1 or DN-EXO1 (EXO1366-846), which lacks the 
entire catalytic domain. By sequencing we verified that the cloning resulted in 
correct in frame junction of the bait sequences to the LexA DNA binding 
domain. Since the full length EXO1 was not expressed from the bait plasmid we 
used the properly expressed DN-EXO1 construct to perform the Yeast two-
hybrid experiments (Fig.16A). We tested the expressed bait construct (pLexA-
DN-EXO1) for self-activation by co-transforming it into the THY.AP4 yeast 
reporter strain with the empty prey plasmid (pACT2). To assess the level of 
self-activation of our bait construct we grew the transformants on different 
selective plates (SD-TL, SD-TLH and SD-TLAH). The DN-EXO1 bait 
construct did not show any self-activation as demonstrated by the absence of 
colonies on SD-TLH and SD-TLAH plates (Fig.16B). 
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Fig.16 Validation of the tools for the yeast two-hybrid screen. A) Western Blot analysis to test 
the expression of the bait construct in the reporter strain THY.AP4. The pLexA-ΔN-EXO1 is 
well expressed and will subsequently be used for the screening approach B) Self-activation 
assay. Growth on selective plates -TLH and –TLAH confirms that the bait construct pLexA-
ΔN-EXO1 is not self activating (in the absence of an interaction) and likewise can be used to 
screen a cDNA library 
 
In order to increase the screening stringency we ran a pilot screen to 
determine the amount of 3-amino-1,2,4-triazol (3-AT) that may have to be 
included to the selection plates. 3-AT modulates the sensitivity of the HIS3 
reporter gene by acting as a competitive inhibitor of the His3 protein. Since we 
could hardly spot any background colonies growing on the selective plates with 
increasing 3-AT concentrations or without, we concluded that we do not need to 
complement the selection plates to screen our DN-EXO1 bait construct (data 
not shown). For the Yeast two-hybrid screen 56µg of a blood peripheral cDNA 
prey library were transformed into the THY.AP4 reporter strain expressing our 
DN-EXO1 bait construct. The transformed cells were plated on 32 150mm 
diameter SD-TL and SD-TLAH dishes each. From the control plates we 
calculated the total number of transformants (1,1*106) and likewise we achieved 
a transformation efficiency of 3,93*104 (clones/µg DNA). From the SD-TLAH 
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selection plates we isolated 135 positive clones and tested them for ß-
Galactosidase activity. Only the clones that were positive for both parameters, 
the growth and the colorimetric markers, were further considered. Their 
plasmids were isolated by standard procedures from the yeast cells and re-
transformed into Escherichia coli (E. coli), where we could specifically select 
and amplify the prey plasmids. These isolated prey plasmids were sequenced 
and the obtained sequences were subjected to a blast search to uncover the 
putative interacting proteins. Like any genetic selection system, the Yeast two-
hybrid screening system will isolate a number of false positives. These clones 
will result in a his+/ade+/lacZ+ phenotype independent of a true interaction. The 
sequences obtained from the blast search allowed us to exclude all the clones 
that were out of frame or inverted. Additionally we could discard the clones 
containing typical false-positives like small “sticky” peptides. The remaining 
twelve potentially interesting positive clones were subjected to a bait 
dependency assay. The bait dependency test is normally performed to confirm 
the interactions found in the screening approach and serves to eliminate those 
preys that non-specifically interact with any co-expressed bait, the so-called 
false positives. For this approach the plasmids containing the putative novel 
interacting protein were retransformed into the reporter strain expressing either 
the DN-EXO1 bait construct or, as a negative control, a non-cognate bait 
construct: LaminC. The resulting co-transformants were assayed again for 
activation of reporter genes and in this manner false-positive interaction 
partners could be removed (Fig17). 
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Fig.17 Bait dependency assay confirming the specificity of the interaction partners found in the 
Y2H screen. Except for the Testis zinc finger (Testis z.f.), showing a non-specific interaction 
with the unrelated bait protein LaminC, all other isolated EXO1 interaction partners showed to 
be bait specific. 
 
The presence of a known EXO1 binding protein among the verified hits, 
namely MLH1 (Table 2), confirmed the quality and reliability of the assay. 
Three 14-3-3 isoforms, namely beta, epsilon and zeta, were the highest hits 
(Table 2), with the b- being more represented than the e- and z-isoform. 
According to the results provided by the X-Gal assay, the strength of the 
EXO1/b-isoform interaction appeared to be of the same order of the 
EXO1/MLH1 interaction, whereas e- and z-isoform were less potent EXO1 
interacting partners (Fig.17 and Table2). Another interesting putative EXO1 
interacting protein was CAF1 (chromatin assembly factor 1), but according to 
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the X-Gal assay, the strength of this interaction was rather weak or it could be a 
transient interaction partner (Fig.17 and Table2). 
 
 
Table 2 Summary of the hExo1 Yeast two-hybrid screen, indicating the function of the 
interaction partner, the abundance of the isolated clones in the screen and the interaction 
strength which is reflected by the β-Galactosidase activity in the X-gal assay. 
 
 
2.3. Confirming the interaction between human EXO1 and 14-3-3 and 
refining the interaction domain 
 
To confirm the data obtained in the yeast two-hybrid screen by an 
independent technique, we performed co-immunoprecipitation experiments. 
Given the low abundance of EXO1 in the cell (El-Shemerly, 2005), we 
transiently transfected HEK-293 cells with an Omni-tagged EXO1 construct 
(El-Shemerly, 2005) or with Omni-tagged EXO1 deletion mutant constructs. 
We immunoprecipitated the expressed protein using a pan-14-3-3 antibody and 
detected the proteins with the same pan-14-3-3 antibody or with an Omni 
antibody. The data showed that Omni-EXO1 and 14-3-3 proteins could be 
recovered as a complex (Engels et al. 2010 and Fig.18). Moreover, does the data 
suggest that the interaction domain on human EXO1 falls within an area 
spanning amino acids 366 - 548, since interaction is lost with the smallest 
EXO1 deletion mutant (1-348) but it is detectable with the second smallest 
EXO1 deletion mutant (1-548) (Fig.18). Accordingly, in the yeast two-hybrid 
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assay a construct containing an N-terminal deletion (366-846) showed 
interaction with 14-3-3 (Fig.17). 
 
Fig.18 Co-immunoprecipitation experiment confirming the interaction data from the yeast two-
hybrid screen and refining the interaction domain to a region spanning amino acids 366-548 of 
human EXO1 
 
Next, we decided to assess the physiological significance of the 
EXO1/14-3-3 interaction. Previous studies carried out in the laboratory showed 
that human EXO1 is phosphorylated at nine residues (8 Ser, 1 Thr) under basal 
conditions and at three additional sites (2 Ser, 1 Thr) upon HU treatment. These 
three HU-induced sites of phosphorylation (S454, T621 and S714) conformed 
to the requirement for recognition by CHK1/CHK2, MAPK/SAPK and 
ATM/ATR, respectively (El-Shemerly et al. 2008). We therefore speculated that 
these sites, when phosphorylated might be required or at least facilitate binding 
of 14-3-3 proteins. We therefore tested the wild type EXO1, the S714 to alanine 
mutation and the S454, T621 and S714 to alanine triple mutation for interaction 
with 14-3-3 under basal conditions and upon HU treatment. The data showed 
that treatment with HU did not cause any variation of the interaction in the 
mammalian system. Neither did the single phosphoserine to alanine mutation 
nor the triple mutant changed the interaction strength (Fig. 19).  
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 Fig.19 Co-Immunoprecipitation experiment to test if any of the HU induced phosphorylation 
sites on human EXO1 might influence the binding to 14-3-3 proteins 
 
As these experiments have been carried out with overexpressed human 
EXO1, we cannot exclude the possibility that we have been looking at a quite 
artificial situation. The fact that we cannot detect any difference in interaction 
upon HU treatment or upon phosphoserine modifications might be due to this 
set up. 
In order to obtain a clear-cut answer we decided to employ the yeast 
Saccharomyces cerevisiae as model organism, a system where only two 14-3-3 
proteins are present, namely Bmh1 and Bmh2. In preliminary experiments we 
examined whether yeast Exo1 and 14-3-3 proteins interact. A C-terminal Myc- 
or a HA-tag was added to the endogenous EXO1 or BMH1/BMH2 genes, 
respectively. Immunoprecipitation experiments showed that Exo1 formed 
complexes with Bmh1 or Bmh2 in a HU-dependent manner (Engels et al. 
2010). 
Taken together, these data suggest that the EXO1/14-3-3 interaction is 
conserved from yeast to mammalian cells. Moreover, the observation that such 
interaction is HU-dependent in yeast, suggests that it might have a functional 
role during DNA replication or in response to other DNA damages. 
 
 
2.4. Sensitivity to genotoxic agents 
 
Using Saccharomyces cerevisiae as model organism we had the 
possibility to test the contributions of the proteins identified in our two-hybrid 
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screen to the resistance against a set of genotoxic agents, by examining defined 
genetic backgrounds. We tested the sensitivity of different combinations of 
genetic backgrounds to Doxorubicin, which is commonly used as cancer 
therapeutic under the name of Adriamycin, and to UV light. Adriamycin is a 
DNA intercalating agent that is thought to interfere with topoisomerase II, thus 
leading to a replication block. As expected, strains carrying a mutation in 14-3-3 
were slightly more sensitive to low doses of Adriamycin when compared to 
wild type cells (Fig.20). On the other hand, low doses of UV radiation did not 
lead to a significant increase in sensitivity in the different genetic backgrounds 
(Fig.20). 
 
 
Fig.20 Adriamycin and UV-sensitivity assay. Wild type, bmh1-280 bmh2Δ, bmh1-280 bmh2Δ 
exo1Δ, bmh1-266 bmh2Δ, bmh1-266 bmh2Δ exo1 Δ, rad53-K227A, exo1Δ and rad53-K227A 
exo1Δ cultures were grown exponentially. Serial dilutions (1:10) were spotted on YPD plates 
containing the indicated amount of Adriamycin or spotted on YPD plates that were irradiated 
with the indicated dose of UV light, and grown for 3 days before scoring. 
 
Next we went on to test the sensitivity of these strains to MMS (methyl 
methanesulfonate), an alkylating agent that is currently used in cancer therapy. 
As expected and previously reported (Lottersberger et al, 2003), the 14-3-3 
strain bmh1-280 bmh2Δ was very sensitive to MMS, nearly to the same extent 
than the rad53 strain (Fig.21). Since deletion of Exo1 can partially rescue the 
defects of a Rad53 strain in response to MMS (Fig.21), we were very curious to 
see whether knocking out Exo1 in the 14-3-3 strain would give a similar 
pattern. Unfortunately, we did not observe any positive or negative genetic 
interaction between 14-3-3 and Exo1 upon MMS treatment (Fig.21). 
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Fig.21 MMS sensitivity assay. Wild type, rad53-K227A, exo1Δ, rad53-K227A exo1Δ, bmh1-
280 bmh2Δ, bmh1-280 bmh2Δ exo1Δ, bmh1-280 bmh2Δ rad53-K227A and bmh1-280 bmh2Δ 
rad53-K227A exo1Δ cultures were grown exponentially. Serial dilutions (1:10) were spotted on 
YPD plates and grown for 3 days before scoring. 
 
 
Finally, the response that by far was the most interesting to us concerned 
the effect of HU, which is also used for several medical applications. We 
reasoned that HU is well suited to study the effect of gene deletion on DNA 
replication since it causes fork stalling by depleting the nucleotide pool. The 14-
3-3 strain bmh1-280 bmh2Δ appeared to be very sensitive to HU treatment, 
virtually to the same extent displayed by the rad53 strain (Fig.22). Analogously 
to the MMS treatment, Exo1 could partially rescue the defects of a Rad53 strain 
in response to HU (Fig.22). Also in this case, we did not observe any positive or 
negative genetic interaction between 14-3-3 and Exo1 upon HU treatment 
(Fig.22). 
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Fig.22 HU sensitivity assay. Wild type, rad53-K227A, exo1Δ, rad53-K227A exo1Δ, bmh1-280 
bmh2Δ, bmh1-280 bmh2Δ exo1Δ, bmh1-280 bmh2Δ rad53-K227A and bmh1-280 bmh2Δ 
rad53-K227A exo1Δ cultures were grown exponentially. Serial dilutions (1:10) were spotted on 
YPD plates and grown for 3 days before scoring. 
 
Although we did not find any direct genetic link between 14-3-3 and 
Exo1, the results led us speculate that a more direct visualization of the 
replication intermediates could provide a better insight into the events occurring 
at the replication fork as well as into the role of these two proteins in the control 
of replication.  
 
 
2.5. Characterization of the replication fork progression and stability in 
HU 
 
Considering that yeast 14-3-3’s, Bmh1 and Bmh2 interact with Exo1 
(Engels et al. 2010), we asked whether this complex would affect stability and 
progression of stalled replication forks. To this end, cells of the above 
mentioned strains, synchronized in G1 by alpha-factor treatment, were released 
into medium containing HU and replication intermediates (RIs) were examined 
by neutral-neutral 2D gel electrophoresis (2D gels) (Friedman and Brewer 
Meth. in Enzymol. 1995).  
The probes that were designed to visualize replication fork progression 
in a region of Chromosome III that contains an early S-phase firing origin 
(ARS305) (Newlon et al., 1993), three contiguous passively replicated regions 
(Part A, B and C) and a further region including the dormant origin ARS301 
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(Part D) (Lopes et al.  2001), are shown in (Fig.23). The lower panel of the 
figure provides a schematic representation of the typical structures that can be 
visualized by means of 2D gels (Fig.23). 
 
Fig.23 Schematic representation of Chromosome III and of the replication intermediates that 
can be visualized with the employed technique 
 
As compared to wild-type (Fig.24), bmh1bmh2 cells showed the same 
kinetics of origin firing, albeit with slightly lower efficiency as revealed by the 
intensity of the bubble arc at 30 min (Fig.25). Progression of the replication 
forks in HU from ARS305 across the region of Part A (positioned 5 Kb to the 
left of ARS305) was completed after 2-3h in wild-type cells, with the peak of 
intermediates detectable after ~1h. In bmh1bmh2 cells the first intermediates 
appeared on this region with 30 min delay, whereas the peak of intermediates 
was delayed of ~2h as compared to wild-type cells. This pattern is indicative of 
a significant decrease in the rate of the replication fork progression in HU 
(Fig.24 and Fig.25 and Engels et al. 2010). 
Since it was previously shown that yeast 14-3-3 proteins bind to the 
checkpoint kinase Rad53 (Usui and Petrini, 2007), we asked whether the slow 
fork progression in bmh1bmh2 cells might be solely due to checkpoint defects. 
To address this issue, we compared Rad53-mutant cells to bmh1bmh2 cells. 
Both the destabilization of replication intermediates (Fig 27 ARS305 and Part 
A) and the uncontrolled firing of dormant origins displayed by rad53-K227A 
cells (Fig.26 Part D) were absent in bmh1bmh2 cells (Fig.25). As previously 
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reported, deletion of EXO1 in the checkpoint defective background led to a 
rescue of the striking RAD53 phenotype to almost wild type situation (Cotta-
Ramusino et al., 2005) (Fig.26, Fig.27 and Fig.24), or to the phenotype of the 
EXO1 deletion alone, which looks indistinguishable from wild type (Fig.27, 
Fig.28 and Fig.24). 
 
Fig.24 Time-course resolution by 2D gel analysis of replication intermediates obtained from 
wild type cells grown in the presence of 0.2 M HU after release from G1. 
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Fig.25 Time-course resolution by 2D gel analysis of replication intermediates obtained from 
bmh1-280 bmh2Δ strain grown in the presence of 0.2 M HU after release from G1. 
 
Fig.26 Time-course resolution by 2D gel analysis of replication intermediates obtained from 
rad53K227A strain grown in the presence of 0.2 M HU after release from G1. 
 
 70 
 
Fig.27 Time-course resolution by 2D gel analysis of replication intermediates obtained from 
rad53K227A exo1Δ strain grown in the presence of 0.2 M HU after release from G1. 
 
Fig.28 Time-course resolution by 2D gel analysis of replication intermediates obtained from 
exo1Δ strain grown in the presence of 0.2 M HU after release from G1. 
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Since it is known that EXO1 deletion has a tremendous effect on 
replication fork stability in checkpoint defective cells (Cotta-Ramusino et al. 
2005) and that Exo1 interacts with 14-3-3 proteins, we speculated that deletion 
of EXO1 might also rescue the phenotype of 14-3-3 deficient cells.  However, 
we observed that deletion of EXO1 in a 14-3-3 deficient background did not 
rescue the slow fork progression phenotype (Fig.24 and Fig.29). 
Combined deficiency of Rad53 and 14-3-3 proteins had a synergistic 
effect on the destabilization of replication intermediates, arguing that their 
effect on replication forks can be clearly dissected (compare Fig.30 with Fig.25 
and Fig.26). 
Deletion of Exo1 in this background led to a rescue of the destabilization 
of the replication intermediates but did not rescue the slow fork progression 
pattern, which is due to lack of 14-3-3’s (Fig.31), and the firing of silent origins, 
which is due to lack of Rad53 (Fig.31). 
 
Fig.29 Time-course resolution by 2D gel analysis of replication intermediates obtained from 
bmh1-280 bmh2Δ exo1Δ strain grown in the presence of 0.2 M HU after release from G1. 
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Fig.30 Time-course resolution by 2D gel analysis of replication intermediates obtained from 
bmh1-280 bmh2Δrad53K227A strain grown in the presence of 0.2 M HU after release from G1. 
 
Fig.31 Time-course resolution by 2D gel analysis of replication intermediates obtained from 
bmh1-280 bmh2Δ rad53K227A exo1Δ strain grown in the presence of 0.2 M HU after release 
from G1. 
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2.6. Recovery from a HU induced replication block 
 
Since the results presented above clearly indicate that both 14-3-3 
proteins and Exo1 are involved in the dynamic events at stalled replication 
forks, we went on to analyze the recovery from HU induced replication fork 
stalling by flow cytometric analysis and 2D gel. The 2D gel uncovered that 
similar to checkpoint defective cells, 14-3-3 cells were also defective in 
resuming replication after the HU induced block. However, the replication 
intermediates observed in the bmh1bmh2 strain were not destabilized and 
degraded as those detected in the Rad53K227A strain. Despite this, also such 
intermediates failed to resume replication (Fig.32). While EXO1 deletion in the 
checkpoint defective background stabilized the replication intermediates, it did 
not affect the ability of these cells to resume replication. The same was 
observed to be the case upon deletion of EXO1 in the 14-3-3 defective 
background (Fig.32). 
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Fig.32 2D gel analysis of replication intermediates obtained from wild type, rad53-K227A, 
exo1Δ, rad53-K227 exo1Δ, bmh1-280 bmh2Δ, bmh1-280 bmh2Δ exo1Δ, bmh1-280 bmh2Δ 
rad53-K227A, bmh1-280 bmh2Δ rad53-K227A exo1Δ strains grown in the presence of 0.2 M 
HU for three hours before release into YPD for 1 hour 
 
In order to obtain a better time course resolution of the recovery from a 
HU induced replication block, we decided to analyze the pattern of recovery by 
flow cytometric analysis. In this setting we had the possibility to analyze many 
time points to get a more complete picture. Flow cytometric analysis confirmed 
the slow recovery and revealed that deletion of EXO1 in the bmh1bmh2 cells led 
to a partial rescue of the phenotype. Such effect could be best seen at the 120 
minutes time point after release from HU (Fig.33). 
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Fig.33 Time-course FACS analysis of wild type, exo1Δ, bmh1-280 bmh2Δ, bmh1-280 bmh2Δ 
exo1Δ, strains grown in the presence of 150 mM HU for the indicated time before release into 
YPD for the indicated time. 
 
 
2.7. Phosphorylation of Rad53 and Exo1 regulate checkpoint and cell cycle 
 
The above displayed evidence prompted us to ask whether EXO1 
deletion in bmh1bmh2 cells may affect Rad53 activity. Western blot analysis 
showed that, compared to wild type cells, Rad53 was hyperphosphorylated in 
HU-treated bmh1bmh2 cells and that its dephosphorylation was retarded during 
the HU-recovery phase, thus correlating with the described replication restart 
defect. Importantly, deletion of EXO1 in 14-3-3-deficient cells re-established to 
a great extent the pattern of rapid Rad53 dephosphorylation in the recovery 
phase, substantiating the flow cytometry data (Engels et al. 2010). 
Our lab has previously shown that upon replication perturbations, human 
EXO1 undergoes rapid phosphorylation that targets it for degradation to prevent 
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any unscheduled nucleolytic activity (El Shemerly 2005). Recently, yeast Exo1 
was also shown to undergo Mec1/Rad53-mediated phosphorylation, a post-
translational modification that regulates its activity at telomeres (Morin et al. 
2008). This evidence prompted us to ask whether yeast Exo1 would also 
undergo phosphorylation upon replication fork stalling. The evidence that we 
present in (Engels et al. 2010) clearly shows that yeast Exo1 was 
phosphorylated in response to HU and that Exo1 phosphorylation was Mec1-
dependent. Most importantly, we show that the high stoichiometry of Exo1 
phosphorylation observed in wild type cells could not be reached in 14-3-3 
deficient cells and additionally, that the rate of Exo1 dephosphorylation upon 
recovery from HU was considerably reduced in 14-3-3 deficient cells (Engels et 
al. 2010).  
 
 
2.8. Exo1 dependent accumulation of ssDNA gaps behind the fork in 
bmh1bmh2 cells 
 
In order to get more structural insights into the events at stalled 
replication forks, we used electron microscopy to directly visualize the 
structures that arise in response to HU treatment. Therefore, we synchronized 
the cells in G1 and released them for 1 or 2 hours, respectively, in YPD medium 
containing 0.2 M HU. Cells were cross-linked in vivo with psoralen, enriched in 
replication intermediates by BND cellulose chromatography, and analyzed by 
electron microscopy (EM) under non-denaturing conditions (Lopes 2009). 
Initially, for most strains and time points, 30 replication intermediates were 
scored and analyzed to obtain a first glimpse of the phenotype. After screening 
the different time points and strains, we focused on the one-hour HU time point 
because the observed phenotype was most pronounced at that time. For each 
strain, showing an interesting phenotype, and the relevant control strains, more 
or less 100 replication intermediates were analyzed in duplicate. Phenotypes 
characteristic of checkpoint defects (Sogo et al, 2002) were not observed in 14-
3-3 deficient cells: ssDNA regions directly at the elongation points were as 
frequent and long as in wild-type cells and no fork reversal could be observed 
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(data not shown). However, 14-3-3-deficient cells showed a dramatic 
accumulation of ssDNA gaps behind the replication fork (Engels et al. 2010). 
Statistical analysis indicated that approximately 50% of all replication 
intermediates analyzed displayed one or more ssDNA gaps (Engels et al. 2010). 
Interestingly, deletion of EXO1 in bmh1bmh2 cells completely suppressed this 
phenotype, leading to a reduction of the ssDNA gaps behind the fork to a level 
similar to wild-type or exo1Δ cells  (Engels et al. 2010). The comparison of 
ssDNA gaps length scored by EM evidenced a striking difference: whereas 
bmh1 bmh2 cells displayed a significant number of large size gaps (>0.5 Kb), 
the latter were absent in bmh1bmh2 exo1Δ cells (Engels et al. 2010). The 
findings from this and the previous section are described in more details in 
(Engels et al., 2010). 
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3. DISCUSSION 
 
The present study describes a novel role of 14-3-3 proteins as key 
regulators of Exo1 function and in promoting fork progression, stability and 
restart in response to DNA replication perturbations. The identification of 14-3-
3’s as human EXO1 interaction partner by means of a yeast two-hybrid screen 
was the starting point for this project. The yeast two-hybrid screening approach 
is a very useful genetic assay when it comes to identify and characterize 
interactions between soluble proteins. This system was originally developed by 
Fields and Song (1989) to detect protein-protein interactions in a cellular 
setting. The system is based on the modular nature of transcription factors, 
which have a DNA binding domain and an activation domain. The bait protein 
of interest is fused to the DNA binding domain and as a prey, a library of cDNA 
fragments is fused to the activation domain of a transcription factor. When 
expressed separately in a yeast reporter strain these constructs do not lead to an 
activation of the reporter genes. However if bait and prey constructs are co-
expressed in the same yeast cell and the bait protein of interest interacts with a 
prey protein, this leads to the reconstitution of a transcription factor, which will 
activate the yeast reporter genes and likewise enable the isolation and 
characterization of the interacting proteins. We first tested if we could express 
the full length human EXO1 fused to the DNA binding domain in the yeast 
reporter strain. Unfortunately the full-length construct was not expressed well or 
it was expressed and rapidly degraded by the yeast cells, possibly as a 
mechanism of self-defence from the unscheduled nuclease activity of the over 
expressed protein. We then decided to test a construct of human EXO1 lacking 
the first 365 amino acids of the protein, the catalytic domain, and found it to be 
well expressed in the yeast reporter strain. These findings confirm our 
speculation that the nucleolytic activity of the over expressed protein was not 
well tolerated by the yeast cells. Although we were using a deletion mutant to 
screen for novel interacting proteins we were quite confident that this construct 
would be useful since it retains the entire interaction domain of EXO1, which is 
responsible for virtually all the interactions that have been described so far. The 
screening approach led to the isolation of nine putative interaction partners of 
human EXO1. The presence of a strong and already known interaction partner, 
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namely MLH1, under the identified candidate proteins validated our screening 
approach and gave us confidence on the reliability of the results. Both the 
frequency with which certain interacting proteins are found in the screening and 
the intensity of the β-Galactosidase reporter activity can give a hint towards the 
interaction strength. According to this criterion, the most promising novel 
interaction partners were the 14-3-3 proteins. We found three different isoforms 
of the 14-3-3 proteins, namely 14-3-3-β, -ε and –ζ. Especially the β-isoform 
was a very abundant hit in the screening and, in addition, the observed β-
Galactosidase activity in the bait dependency assay was of the same order than 
the one observed for MLH1, suggesting that it is indeed a very strong EXO1 
interaction partner. Moreover, does the presence of the other 14-3-3 isoforms 
suggest that this interaction might be crucial for the control of EXO1 since it is 
known that the different homo- and hetero-dimers combinations formed by 14-
3-3 proteins can affect their influence on target proteins. Another interesting 
putative interaction partner that we found in our screening is CAF1A, the 
Chromatin Assembly Factor 1 that is implicated in histone deposition on newly 
synthesized DNA and was previously linked to the mismatch repair system. 
However, according to the β-Galactosidase assay, the strength of this interaction 
is rather weak. We were also unable to confirm this interaction with an 
independent technique such as co-immunoprecipitation (data not shown). Since 
the yeast two-hybrid approach can also indicate weak and transient interactions 
it is possible that this interaction is not strong or enduring enough to be detected 
by co-immunoprecipitation where stable protein complexes are required. 
Co-immunoprecipitation experiments did not only confirm the 
interaction between human EXO1 and 14-3-3’s, but they also allowed us to 
narrow down the interaction domain on EXO1. Using five different deletion 
mutants of EXO1 for IP and combining the results with the yeast two-hybrid 
data we were able to narrow down the interaction domain to a region spanning 
amino acids 366 to 548. Previous work from our lab has shown that, upon HU 
treatment, human EXO1 undergoes rapid phosphorylation that targets the 
protein for degradation (El-Shemerly et al. 2005). Since a role in response to 
replication perturbations has been described for 14-3-3 proteins, we thought that 
the interaction strength might vary in response to HU treatment. On the 
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contrary, we did not observe an enhancement or a reduction of the interaction 
strength in response to HU treatment. Also did mutation to alanine of several of 
the putative 14-3-3 phosphoserine binding sites not change the pattern of 
interaction. Unfortunately, these experiments had to be carried out with 
overexpressed human EXO1, since no good commercial antibody that can 
detect endogenous human EXO1 is available. Given this caveat, we cannot rule 
out the possibility that overexpression of EXO1 might hamper our conclusions.  
Employing the yeast Saccharomyces cerevisiae as model organism we 
were able to address the above questions in a more natural setup by analyzing 
interaction of the endogenous proteins. We found both yeast 14-3-3’s, Bmh1 
and Bmh2 to interact with Exo1 in an HU dependent manner, confirming our 
speculation that the functional relevance of this interaction might be linked to 
events at challenged replication forks. It is conceivable that the HU dependent 
binding in yeast, and the HU independent binding in human cells, might reflect 
the different modes of regulation in mammalian versus yeast cells. In contrast to 
mammalian cells, yeast Exo1 does not undergo degradation upon HU treatment, 
but phosphorylation restrains its nuclease activity (Morin et al. 2008). 
14-3-3 proteins have been implicated in the hypersensitivity to 
genotoxic stress caused by agents such as MMS or HU (Lottersberger et al. 
2003). Since a complete knockout of both isoforms is not viable we employed 
the mutants generated for the authors of the above-mentioned publication. In 
this set up, both BMH1 and BMH2, the major and the minor 14-3-3 isoform, 
respectively, are deleted and BMH1 is complemented by mutant BMH1 alleles 
that cause several defects due to reduction of the functional level of 14-3-3 
proteins but confer viability to the cells. We employed two different 14-3-3 
mutant alleles, of which one is a temperature sensitive allele bmh1-266 bmh2Δ, 
bearing three point mutations. This allele allows to completely switch off the 
14-3-3 function by shifting the cells to the non-permissive temperature of 37°C. 
The other mutant allele that we subsequently used for most studies is bmh1-280 
bmh2Δ, carrying a single point mutation that renders the cells hypersensitive to 
HU and MMS, two agents that interfere with DNA replication. In order to 
assess genetic interactions, we deleted EXO1 in 14-3-3 deficient cells and 
additionally combined them with a Rad53 mutant allele rad53K227A, which in 
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contrast to a complete knock out, allows the cells to survive because of the 
residual checkpoint kinase activity. These strains were employed to assess the 
individual genetic contributions to the resistance against various genotoxic 
agents. As reported previously, we observed that the bmh1-280 bmh2Δ and 
rad53K227A strains were sensitive to MMS and HU treatment and deletion of 
EXO1 could suppress the sensitivity of the checkpoint defective rad53K227A 
allele towards both agents. The rescue of the viability in response to MMS was 
reported previously (Segurado and Diffley, 2008). On the contrary, Segurado 
and Diffley did not observe the EXO1 deletion-dependent rescue to HU 
treatment that we report in our study. This is very likely due to the conditions 
used: whereas these authors used HU at 20 mM, a dose at which both strains are 
unviable and therefore one cannot observe a rescue, we used a very low dose of 
5mM. Unfortunately we did not observe any genetic interaction between EXO1 
and BMH1 or BMH2 in response to the employed genotoxic agents. The bmh1-
280 bmh2Δ rad53K227A strain showed a slightly enhanced sensitivity towards 
HU treatment when compared to the individual mutants. This finding supports 
the idea of a synergistic effect between 14-3-3’s and Rad53 proteins in response 
to replication fork stalling. This induces to further argue that both proteins are 
not only working in the same pathway, where 14-3-3’s physically bind and 
stabilize an active conformation of Rad53 (Usui and Petrini, 2007), but 
additionally point to a secondary pathway by which 14-3-3 proteins alone might 
contribute to the stability or progression of replication forks in response to HU 
treatment.   
By means of 2D gel electrophoresis we were able to show that 14-3-3 
proteins are required to sustain the rate of DNA synthesis under low nucleotide 
conditions. In 14-3-3 deficient cells, fork progression is markedly reduced, to an 
extend comparable to the rad53 K227A cells with the striking difference that 
processing and collapse of the slow progressing forks and late origin firing does 
not occur. This is a very important piece of evidence, since the data on physical 
and functional interaction of 14-3-3 proteins and Rad53 might have been taken 
as suggestion of an indirect effect of 14-3-3 proteins on fork progression: our 
data now allow to definitely rule out this possibility.  
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Compared to wild type cells the only difference that we observed in 14-
3-3 deficient cells was slow fork progression from early firing origins. These 
findings are very interesting considering that Mec1 and Rad53 prevent late 
origin firing, stabilize stalled replication intermediates and block entry into 
mitosis. However, the fourth cellular response to disruption of DNA replication, 
namely slowing of the elongation, so far could not be attributed to any of these 
kinases or to any other factor. Although it was previously shown that 14-3-3 
proteins bind origins of replication and cruciform DNA (Alvarez et al., 2002), 
we cannot fully support such argument, which claims that the slow cell cycle 
progression observed in 14-3-3 deficient cells is solely due to defective origin 
firing. Although we observe a slight reduction of the kinetics of origin firing by 
2D gel, the cell cycle defect cannot be attributed to this event alone. In the latest 
publication from this laboratory the authors claim that the slow cell cycle 
progression in 14-3-3 deficient cells might also be related to defects during the 
elongation steps. Compelling evidence for this argument is, however, not 
provided in the study (Yahyaoui and Zannis-Hadjopoulos, 2009). 
The slow fork restart that we observe in 14-3-3 deficient cells upon HU 
removal, points to a recovery defect without evident fork collapse. The large 
majority of recovery defects occur when fork architecture is severely 
compromised. Our data, however, indicate that misregulation of the replisome, 
without dramatic physical processing of the forks, might be sufficient to prevent 
fork restart. We obtained the first hint pointing at a regulatory role of 14-3-3 
proteins on Exo1 at replication forks, when we performed a time-course flow 
cytometric analysis. Upon recovery from a HU induced replication block, 
deletion of EXO1 in a bmh1-280 bmh2Δ strain led to a slightly faster recovery. 
This rescue upon EXO1 deletion in bmh1-280 bmh2Δ cells is also confirmed by 
a faster Rad53 inactivation upon HU removal. Finally, the improved resolution 
of Exo1 phospho-forms obtained in our study, in comparison to previously 
published data, led us conclude that the Mec1-dependent Exo1 
hyperphosphorylation in response to replicative stress is mediated by 14-3-3 
proteins. The observation that in bmh1-280 bmh2Δ cells, Rad53, which is 
another Mec1-dependent checkpoint target, was promptly phosphorylated, 
supports the idea that defective Exo1 phosphorylation in absence of 14-3-3 
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proteins is not an indirect consequence of slower fork progression and/or 
defective checkpoint activation. Since phosphorylation restrains yeast Exo1 
activity at telomeres (Morin et al. 2008), we propose that this may also be the 
case at stalled forks of replication and that 14-3-3 proteins may act as a platform 
to mediate phosphorylation events at such structures. Electron microscopy 
provided direct, in vivo evidence for uncontrolled Exo1 activity in HU-treated 
14-3-3 deficient cells. The accumulation of long ssDNA gaps behind the slow 
moving replication forks in bmh1-280 bmh2Δ cells, was completely suppressed 
by EXO1 deletion. 
These findings are of high significance, since they suggest that a loose 
control of Exo1 activity may render DNA synthesis more discontinuous in 
conditions of replicative stress. The stalling of the polymerase due to low 
nucleotide levels might lead to increased repriming events, thus raising the 
number of accessible 5’-ends, available for processing by Exo1. It is 
conceivable that in this setting, a strict control of Exo1 activity is required to 
limit damage. The resolution limit of electron microscopy might have prevented 
the detection of these nicks/small gaps in this as well as in previous studies 
(Sogo et al. 2002). However, in 14-3-3 deficient cells where control of Exo1 
activity by phosphorylation is impaired, the unleashed exonucleolytic activity 
would enlarge gaps beyond the detection limit. 
The fact that EXO1 deletion suppresses the accumulation of ssDNA gaps 
in 14-3-3 deficient cells but not the HU sensitivity or only partially the recovery 
defect upon HU removal, suggests that 14-3-3 proteins might regulate 
additional targets (depicted as factor X in Fig.34) by modulating their 
phosphorylation, during replication stress (Fig.34).  
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Fig.34 Hypothetical model showing the regulation of different targets by 14-3-3 proteins 
 
Given the role of 14-3-3 proteins as integrators of signaling pathways 
(Morrison, 2009) and the multiplicity of their targets (Jin et al. 2004), 14-3-3 
proteins might function as central regulators of the checkpoint response. 
Considering previously reported cases (Braselmann and McCormick) and the 
dynamic nature of 14-3-3 dimers (Yang et al. 2006), one may envisage a role 
for 14-3-3 proteins as docking clamp tethering Exo1 and the kinase controlling 
its activity. The most promising kinase candidate would be the Rad53 kinase, as 
it was previously shown to interact with 14-3-3 proteins (Usui and Petrini, 
2007) and it is required for Exo1 phosphorylation (Morin et al., 2008). 
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4. CONCLUSIONS AND PERSPECTIVES 
 
We can conclude from our results, that 14-3-3 proteins are in vivo 
interaction partners of Exo1, both in yeast and mammalian cells. Yeast 14-3-3-
deficient cells fail to induce Mec1-dependent Exo1 hyperphosphorylation upon 
replication fork stalling and therefore accumulate Exo1-dependent ssDNA gaps 
at stalled forks. Accumulation of ssDNA gaps causes persistent checkpoint 
activation in these cells and contributes to the exacerbated recovery defects. 
Moreover, we can conclude that 14-3-3 proteins promote the rate of fork 
progression under limiting nucleotide concentrations. 
This work clarifies events occurring at stalled replication forks, and 
proposes 14-3-3 proteins as central integrators of signals that regulate fork 
stability, progression and processing. 14-3-3 proteins regulate the 
phosphorylation of Exo1 and other unknown targets and likewise control their 
activity (Fig.34).  
Challenges lying ahead consist in the identification of components of the 
replisome, or proteins controlling them, that may be 14-3-3 targets, as well as in 
the elucidation of the exact mechanism by which 14-3-3 modulate Exo1 activity 
(Fig.34). Additionally, it would be of great interest to confirm in human cells 
the data obtained in the yeast model system. 
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5. MATERIALS AND METHODS 
 
Materials 
 
The antibodies used in this study were: mouse monoclonal anti-LexA 
(sc-7544, Santa Cruz Biotechnology); goat polyclonal Omni-probe (M21, sc-
499, Santa Cruz Biotechnology); rabbit polyclonal anti-pan 14-3-3 (SA-483, 
Biomol); mouse monoclonal anti-HA (12CA5, Sigma) and anti-Myc (9E10, 
Santa Cruz Biotechnology); rabbit polyclonal anti-Rad53 (a kind gift from C. 
Santocanale, Galway, Ireland). 
The chemicals and peptides used in this study were: Hydroxyurea 
(Sigma); Methyl methanesulfonate (Sigma); Adriamycin (Calbiochem); X-gal 
(Qbiogene); a1-Mating Factor (Sigma). 
 
Saccharomyces cerevisiae strains 
 
The yeast strains used in this study are isogenic to W303-1A (wild-type) 
(Thomas and Rothstein, 1989), CY2034 (rad53-K227A), CY5145 (exo1Δ), 
CY5469 (rad53-K227A exo1Δ), KE2 (bmh2Δ bmh1Δ::bmh1-280), KE3 
(bmh2Δ bmh1Δ::bmh1-266), KE4 (bmh2Δ bmh1Δ::bmh1-280 exo1Δ), KE5 
(bmh2Δ bmh1Δ::bmh1-266 exo1Δ), KE7 (bmh2Δ bmh1Δ::bmh1-280 rad53 
Δ::rad53-K227A), KE8 (bmh2Δ bmh1Δ::bmh1-280 rad53 Δ::rad53-K227A 
exo1Δ), KE15 (bmh1-3HA exo1-9myc), KE16 (bmh2-3HA exo1-9myc), THY 
AP4 (ura3, leu2, lexA::lacZ::trp1, lexA::HIS3, lexA::ADE2), YMG1009 (exo1-
9myc), YMG1197 (bmh2Δ bmh1Δ::bmh1-280 exo1-9myc), YLL909 (bmh1-
3HA), YLL910 (bmh2-3HA), YMG1201 (exo1-9myc-HIS3), YMG1215 ( 
mec1Δ sml1Δ exo1-9myc-HIS3). 
 
Yeast two-hybrid screen 
 
The yeast two-hybrid screening was performed with DN-EXO1 
(EXO1366-846) as bait on a cDNA library generated from human peripheral blood 
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mRNA (a kind gift of I. Stagljar, Toronto, Canada) as described previously 
(Jiao R. et al., 2004) and using THY AP4 as reporter strain. 
 
Cell culture 
 
HEK-293 cells were maintained and transiently transfected as described 
(El-Shemerly et al, 2005). 
 
Protein extraction, Western Blotting, Immunoprecipitaion 
 
Human cellular proteins were extracted using ice-cold lysis buffer (50 
mM Tris-HCl pH 7.5, 120 mM NaCl, 20 mM NaF, 1 mM EDTA, 6 mM EGTA, 
15 mM Na-PPi, 0.5 mM Na-orthovanadate, 1 mM benzamidine, 0.1 mM 
phenylmethylsulfonyl fluoride, 1% Nonidet P-40). Protein concentration was 
determined using the Bio-Rad Protein Assay Reagent (Bio-Rad). Omni-EXO1 
or 14-3-3 proteins were immunoprecipitated from 2 mg total HEK-293 cell 
extracts for 3h at 4°C using either the Omni-probe antibody or the pan-14-3-3 
antibody. Antibodies were captured using protein G-agarose beads (Santa Cruz 
Biotechnology) for 1h at 4°C. Beads were washed in 2x 1 ml TNET ice-cold 
buffer (50 mM Tris-HCl pH 7.5, 140 mM NaCl, 5 mM EDTA, 1% Triton X-
100) followed by 2x 1 ml ice-cold TNE buffer (50 mM Tris-HCl pH 7.5, 140 
mM NaCl, 5 mM EDTA) and heated for 10 min at 95°C in 2 x Laemmli sample 
buffer. Proteins were resolved on 10% SDS-polyacrylamide gels, transferred to 
polyvinylidene difluoride (PVDF) (GE-Healthcare) and the membrane was 
probed with appropriate antibodies. Immune complexes were revealed using the 
enhanced chemiluminescence system (GE-Healthcare). 
 
Yeast cellular proteins were extracted using ice-cold lysis buffer (25 mM Tris-
HCl pH 7.4, 15 mM NaCl, 15 mM EGTA, 1mM NaF, 1mM Na orthovanadate, 
4 mM p-Nitro-Phenyl-Phosphate (pNPP), 0.1% Triton X-100, 1mM PMSF, 
complete protease inhibitors cocktail (Roche)). Protein concentration was 
determined using the Bio-Rad Protein Assay Reagent (Bio-Rad). 14-3-3-HA 
was immunoprecipitated from 10 mg total cell extracts for 2h using the 
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monoclonal HA antibody. The antibody was captured for 1h at 4°C using 
protein G-agarose beads. Beads were washed in 4 x 1ml ice-cold lysis buffer and 
heated for 10 min at 95°C in 2 x Laemmli sample buffer. Proteins were resolved 
on 7.5% or 10% SDS-polyacrylamide gels and detected as described above 
using anti-HA or anti-Myc monoclonal antibodies. 
For Western blot experiments, yeast cellular proteins were extracted 
using the TCA method (Muzi-Falconi M. et al., 1993), resolved on 10% SDS-
polyacrylamide gels and detected with a rabbit polyclonal anti-Rad53 antibody. 
For the visualization of Exo1 phosphorylation, an optimized Phos-tag 
system (5 mM Phos-tag reagent) was employed according to (Kinoshita E. et 
al., 2008). Proteins were transferred to nitrocellulose (porablot NCP, 0.45 µm 
pore size, Machery-Nagel) overnight at room temperature applying constant 
amperage (200 mA) and detected as described above. 
 
Flow cytometric analysis 
 
Flow cytometric analysis was performed as described (Pellicioli, A. et al., 
1999). 
 
2D Gel Electrophoresis and Electron Microscopy 
 
DNA extraction with the CTAB method and neutral-neutral two-
dimensional gel electrophoresis were performed as described (Lopes at al. 
2003). Replication intermediates quantification (Lopes et al., 2001) and EM 
analysis (Lopes M., 2009) were performed as described. 
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